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CHAPTER 1: INTRODUCTION 
 
1.1 Overview of Cardiac Electrophysiology and Arrhythmias 
The human heart is a fascinating machine whose mechanical and electrical synergy 
creates a powerful and efficient dynamic system that beats tirelessly over two billion times 
in an average lifespan. It comprises an intricate synchronous electrical system whose 
rhythmic activation enables the mechanical contraction and relaxation that result in a 
heartbeat. An abnormal heart rhythm (arrhythmia) can be caused by functional 
irregularities in cardiac electrical activity. Arrhythmias are exhibited as unstable variations 
in cardiac cellular electrical impulses, also known as action potential durations (APDs). An 
alarming number of people have been reported to manifest sudden cardiac death (SCD) as 
the first symptom of cardiac arrhythmias, leading to an estimated 600,000 fatalities per 
year. Efforts for decreasing this substantial number have led to the proliferation of medical 
devices, aimed at restoring the normal electrical activity in diseased and failing hearts, with 
over 3 million pacemaker implantations reported in the past decade. However, given the 
complex spatiotemporal dynamics and non-linearity of the human heart, predicting the 
onset of arrhythmias and preventing the transition from steady state to unstable rhythms 
has been an extremely challenging task. 
In order for the heart to function properly, it needs to contract and relax in a 
coordinated fashion. The mechanical contractions of the heart are triggered by electrical 
waves of excitation propagating through the cardiac tissue. In healthy hearts, the electrical 
impulses originate in the heart’s own natural pacemaker, the sinoatrial (SA) node in the 
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right atrium. From the SA node, the electrical impulse excites the atria and causes it to 
contract. Then, after a short delay to allow enough time for the ventricles to fill up, the 
electrical wave travels through the atrioventricular (AV) node, which serves as the 
electrical connection between the atria and the ventricles, to the Purkinje fibers via the 
Bundle of His. Finally, the Purkinje fibers will carry the electrical wave to the ventricles 
causing them to contract. Fig.1.1 depicts the cellular electrical activity corresponding to 
different regions of the heart and its correlation to the average activity recorded on an 
electrocardiogram (ECG). 
Figure 1.1. (A) [Adapted from (Malmivuo and Plonsey, ‘Bioelectromagnetism’)] 
Electrophysiology of the heart with voltage or action potential waveforms for each region 
shown distinctly along with cumulative ECG trace. (B) Ventricular action potential trace 
showing different phases of activation. (C) Correlation between ECG trace and activation 
of different regions of the heart. 
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The contraction of the heart is a phenomenon that is brought about by a well-timed 
summation of single cardiomyocyte contractions. The contraction of each myocyte is 
triggered by the electrical wave of excitation that originates from the SA node as discussed 
in the previous section. Each time a myocyte is triggered, the properties of transmembrane 
ion channels (e.g. sodium, potassium, calcium, etc.) change and a complex movement of 
ions in and out of the cell takes place, thereby causing a cyclic change in the membrane 
potential. This sequence of changes in the membrane potential is known as the action 
potential. The action potential of one myocyte will act as the stimulus to surrounding cells 
through gap junctions and diffusion, thus, eliciting an action potential in downstream cells 
in the conduction system. This process is repeated until the electrical signal propagates 
through the entire heart causing it to contract. 
Arrhythmias are any abnormality in the rhythm or normal electrical conduction 
system of the heart, as described previously. Some common types of arrhythmias are 
described in Table 1.1.  
Type of Arrhythmia Description 
Ventricular Tachycardia (VT) Regular but rapid heart rhythm of 
the ventricles, resulting in abnormally high 
heart rates.  
Ventricular Fibrillation (VF) Irregular, chaotic, and rapid 
ventricular rhythm that causes the 
ventricles to quiver. This results in the 
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heart to not be able to contract or pump 
blood. 
Atrial Fibrillation (AF) Irregular, chaotic rhythm of the 
atria. This causes no atrial hemodynamic 
input to the ventricles and the stasis of 
blood in the atria can result in clot 
formation and stroke. 
Atrial Flutter or Tachycardia Abnormally high atrial rate. 
Bradycardia Slow heart rhythm. 
Heart block Electrical activity in the heart is 
either disrupted or completely blocked as 
the impulse travels from the SA node to the 
ventricles. 
Table 1.1. Common examples of cardiac arrhythmias.  
1.2 Current Pacemakers and Therapies  
Cardiac pacemakers are being used as a therapeutic device to regulate the heart 
function and rhythm in patients with abnormal cardiac electrical activity. From treatment 
of bradycardia, heart block and ventricular dysfunction to defibrillation devices that reset 
the electrical activity, a vast array of devices have been designed to regulate cardiac 
function. Past two decades have seen an immense improvement in the pacemaker 
technology, yet they have had limited efficiency in arrhythmia prevention due to two major 
drawbacks. Firstly, the pacing schemes in contemporary pacemakers are based on periodic 
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stimulation approach. In periodic stimulation there is a dependence of the diastolic interval 
(DI) (cardiac relaxation phase), on the preceding APD leading to an inherent feedback. The 
presence of feedback makes the heart more susceptible to electrical destabilization and 
formation of alternans, a beat-to-beat alternation of the APD in the heart. Observed as a 
periodic variation in the amplitude or shape of the T-wave in an electrocardiogram (ECG), 
alternans is believed to be a direct precursor to ventricular fibrillation (VF) or abnormal 
disordered electrical activity of the heart [1-4]. VF can then lead to SCD which is one of the 
leading causes of natural death in the US. Previous studies have established a plausible link 
between alternans and ventricular arrhythmias suggesting that elimination of alternans 
could lead to the prevention of VF and eventual arrhythmias in the heart [3, 5-7]. 
Secondly, there has been an increasing need for a more physiologically relevant 
pacing technique with one approach being to incorporate heart rate variability (HRV) 
information in pacemakers. Under normal conditions, the heart rate is never constant and 
is a cumulative result of a complex interplay between different physiological systems. 
Clinically, low HRV has been known to be a marker of arrhythmias [8-11]. However, recent 
numerical simulations have shown that incorporation of HRV in pacing can have a 
contradictory pro-arrhythmic effect in the presence of feedback, while being ineffective in 
the absence of feedback [12]. Understanding the effect of HRV on feedback modulation 
forms an important aspect in the design and development of anti-arrhythmic pacing. 
Inspite of the above mentioned shortcomings, most contemporary pacemakers still 
use periodic stimulation to restore normal cardiac rhythm, potentially promoting electrical 
instability in the heart. This creates a pressing need to better understand paced cardiac 
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dynamics and develop anti-arrhythmic pacing techniques that would prevent cardiac 
arrhythmias. The focus of my research was to develop and implement a novel anti-
arrhythmic pacing mechanism that eliminates the inherent electrical instabilities of 
periodic pacing and prevents abnormal cardiac rhythms.   
1.3 Organization of Thesis 
Chapter 2 presents an overview of the electrophysiological concepts pertinent to 
the research and elaborates on the concepts of ‘Restitution’, ‘Feedback’ and ‘Cardiac 
Alternans’. Background information on paced cardiac dynamics and the use of high 
resolution optical mapping for the study of cardiac arrhythmias is also provided. The rest 
of the thesis is divided into three main parts: 
PART 1: Prediction of cardiac alternans: Here, Chapter 3 describes the pacing 
methodology used to induce alternans and the analytical, non-linear dynamical approach 
used to characterize the bifurcation to alternans from steady state cardiac rhythm. Details 
of the experimental investigations performed and the results are also provided. The goal of 
this project was to implement a pacing technique that can be used to characterize the 
transition to alternans, which in turn could be potentially used to predict the onset of 
alternans prior to their occurrence. 
PART 2: Prevention and Control of alternans: Chapter 4 elaborates the 
preliminary experiments performed to investigate the effect of incorporating stochasticity 
or HRV, in periodic pacing. This study utilized the traditional open loop optical imaging 
technique to compare the propensity of stochastic and periodic pacing, to the temporal 
onset of alternans. Chapter 5 details the design and implementation of a novel, real-time 
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closed loop system that enables beat-by-beat cardiac control. Furthermore, it details the 
experiments performed using the closed loop control system, to investigate the anti-
arrhythmic benefits of ‘feedback elimination’ (Constant DI pacing) compared with a) 
traditional periodic pacing that has ‘feedback inherent’; and b) pacing with HRV which 
corresponds to ‘feedback modulation’. This encompasses a detailed spatio-temporal 
assessment of the effect of feedback elimination using beat-to-beat cardiac control, on the 
prevention and control of cardiac alternans. 
PART 3: Investigating effects of parasympathetic modulation of the heart: 
Chapter 6 describes an investigative study performed to evaluate the effects of modulating 
the M2R-Girk4-RGS6 dependent parasympathetic pathway using isolated whole murine 
hearts. The chapter details the structural and ventricular electrophysiological effects of 
parasympathetic stimulation in mice with gain and loss-of parasympathetic function. 
Chapter 7 summarizes the work completed as part of this dissertation by 
highlighting the major findings and discussing the possible future directions for different 
aspects of this research. 
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CHAPTER 2: BACKGROUND 
 
2.1  Paced Cardiac Dynamics 
   The heart comprises of excitable cells that elicit an electrical signal (voltage) in 
response to a stimulus. As described briefly in the preceding section, cardiomyocytes fire 
an action potential with each electrical stimulus applied. Action potential firing is an all-
or-nothing phenomenon wherein a sub-threshold stimulus would elicit no response while 
a super-threshold stimulus would generate an action potential. As shown in Fig.2.1, the 
rate of firing of action potentials can also be controlled by changing the rate of stimulation 
or the time duration between two consecutive stimuli, denoted here as the Basic Cycle 
Length (BCL). As we decrease the BCL, we observe a shortening in APD as action 
potentials fire at a faster rate. This shortening in APD with increase in heart rate is known 
as electrical restitution. 
2.2  Electrical Restitution and Cardiac Alternans 
Electrical restitution is a fundamental characteristic of cardiac cells and plays a vital 
role in maintaining stable electrical function of the heart. At a given heart rate, a shorter 
Figure 2.1: Paced cardiac response (black lines indicate stimuli) 
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APD enables a longer DI interval and in turn, sufficient time for the heart to refill with 
blood. As the heart is paced at progressively increasing rates, it bifurcates from a constant 
APD response at lower frequencies to alternating long-short APD, or alternans, at higher 
frequencies [13-15]. As seen from Fig.2.2, under normal conditions, the heart elicits an action 
potential (AP) for every electrical stimulus applied. A sufficiently large basic cycle length 
(BCL), time interval between two consecutive stimuli, ensures a constant identical AP for 
every stimulus, leading to a 1:1 response. However, as the BCL is decreased, at a certain 
pacing rate the heart transitions to a 2:2 alternating long-short AP response, giving rise to 
alternans. 
2.3  Feedback 
In one of the first studies to characterize APD alternans formation, Nolasco and 
Dahlen used a one-dimensional mapping model with the assumption of constant periodic 
pacing [16]. Specifically, they proposed that the APD generated by the (n+1)st stimulus, 
APDn+1, was completely determined by the preceding DI, DIn: 
     APDn+1 = f(DIn)           (1) 
Figure 2.2: Action potential traces showing A) Constant APD at higher BCL; B) APD 
alternans at lower BCL 
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where, f  is the restitution curve. For periodic stimulation, APD and DI are also related 
through the pacing relation:               
APDn+ DIn = BCL           (2) 
where, BCLn = BCL is constant. Under Eq.2, there is a partial dependence of the DI on the 
preceding APD leading to an inherent feedback.  
Fig.2.3 illustrates the concept of feedback during periodic stimulation. The 
feedback curve represented by Eq. 2 has a slope of -1 during periodic pacing (Fig.2.2B). It 
can be seen from the cobweb diagrams in Fig.2.3, that different responses are generated 
under the pacing relation of Eq.2 and depending on the slope of restitution. Stable 1:1 
responses are elicited for a slope less than one, whereas we get unstable electrical activity 
and alternans for a slope greater than one. The APD responses for these representative 
cases are shown in Fig.2.4. 
Figure 2.3: A), B) Representative curves for Eqs. 1 and 2 respectively; C), D) and E) 
Cobweb diagrams for mapping model in Eq.1 combined with periodic pacing, for 
restitution slope S< 1, S = 1 and S > 1 respectively 
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 Based on Eqs.1 and 2, the restitution hypothesis was proposed and alternans was 
predicted to occur when the magnitude of the slope of the restitution curve, S, exceeded 
one [7, 13, 17], i.e. 
      S =| f '| ≥ 1            (3) 
This led to the proposition that flattening the slope of the restitution curve can help prevent 
the formation of alternans and eventual VF, with several experimental studies 
demonstrating the correlation of alternans with steep restitution slopes [13-15].  
 The presence of feedback causes small changes in DI to translate into subsequent 
changes in the APD, thus enhancing the electrical instability in the heart [12, 18-21]. 
Maintaining a constant DI would eliminate the pacing relation given by Eq.2 making the 
formation of alternans mathematically inexplicable. In the absence of feedback, the 
mapping model in Eq.1 would return a single constant APDn+1 value for a fixed DIn. Based 
on Eq.2, the following relation can be derived:  
     ∆DIn,n-1 =- ∆APDn,n-1           (4) 
Figure 2.4: APD restitution curve; A) Stable 1:1 response for S<1; B) APD alternans at 
for S ≥1 
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Eq.4 describes the feedback inherent in periodic pacing and indicates that small changes in 
DI are inversely proportional to small changes in APD. Based on Eq.4, the slope of 
restitution can be modified to the following: 
              ∆APDn+1,n =S (- ∆APDn,n-1)               (5) 
It is apparent from Eq.5 that for a slope S < 1, small changes in APD die out whereas for S 
> 1, small changes in APD get enhanced during subsequent pacing cycles leading to 
electrical instability of the heart. However, by maintaining a constant DI, the relation 
between APD and DI expressed by Eq.2 can be eliminated, thus eliminating feedback. In 
this case we would generate a constant APD during each pacing cycle corresponding to the 
fixed DI. 
Numerical simulation results of the proposed anti-arrhythmic effects of feedback 
elimination have been published recently [12, 22]. Figs.2.5A and B, show the formation of 
alternans as BCL is progressively decreased for the case of periodic and constant DI pacing 
protocols respectively. As seen from Fig.2.5, elimination of feedback by maintaining a 
constant DI prevented the formation of alternans in an ionic model of isolated cardiac 
Figure 2.5: Change in APD for an ionic model of a canine cardiac action potential paced 
with A) periodic pacing protocol with constant BCL; B) constant DI pacing protocol [12] 
  13 
myocyte. Thus, eliminating feedback and the dependence of DI on preceding APD could 
control the formation of alternans and have beneficial anti-arrhythmic effects. 
2.4  Heart Rate Variability 
Another important physiological phenomenon that needs consideration is the 
presence of HRV and its effect on feedback modulation in the heart. HRV ensures deviation 
of the heart from constant periodic beating under normal conditions and is modulated by 
various physiological factors like sympathetic and parasympathetic nerve activity, 
thermoregulation, respiration, etc [23]. HRV, the variation in time interval between 
heartbeats, can be observed as a change in the RR interval on the ECG (Fig.2.6).  
A major limitation of the restitution hypothesis apart from its basis on periodic 
pacing, is the fact that it does not account for the presence of physiological HRV, which 
can alter cardiac dynamics and hence, the prediction of alternans. HRV can modulate the 
feedback characteristics, leading to different effects in the presence and absence of 
feedback. In order to investigate the formation and prevention of alternans, the current 
Figure 2.6: ECG trace of adult male during sinus rhythm [24] 
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concept of electrical restitution needs to be extended to a more realistic and physiologically 
relevant pacing scheme, by incorporation of HRV in pacing. 
2.5 Need and Significance of Feedback Elimination 
Implantable pacemakers and cardioverter defibrillators are being therapeutically 
used in patients to restore normal cardiac function [25-27]. Cardioverter defibrillators use real 
time heart rate sensing to detect irregular rhythms and shock the heart to save the patient 
from lethal arrhythmias.  Various control algorithms have been developed and 
implemented in pacemakers enabling detection of irregular cardiac rhythms and 
application of rate responsive stimulation for modulation of heart rate [25, 27]. Contemporary 
pacemakers are designed to override the abnormal sinus rhythm and stimulate the heart at 
a constant periodic rate in an attempt to modulate and stabilize the heart. However, an anti-
arrhythmic pacemaker with a physiologically relevant pacing scheme that potentially 
prevents the formation of alternans and eventual VF is yet to be implemented.  
There is great interest and an urgent clinical need in deciphering the mechanisms 
that lead to unstable electrical substrates in the heart and developing pacing techniques that 
prevent irregular rhythms. Over the past two decades, several groups have attempted the 
control of alternans through in-silico, in-vitro and ex-vivo experiments [6, 12, 21, 22, 28-34]. The 
late 1990s and early 2000s reported positive results in controlling alternans in single cell 
models and in-vitro preparations. They mainly utilized an adaptive negative feedback 
algorithm that adjusted the pacing cycle length based on the amplitude of alternans [6, 29, 30]. 
However, control of alternans in more spatiotemporally complex 2D settings proved 
unsuccessful. Eschebarria and Karma [31] adeptly highlighted the challenges in the 
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spatiotemporal control of cardiac alternans revealing that the control failed above a critical 
cable length. Similar findings were reported by Christini et.al [33] where control became 
attenuated spatially as the alternans amplitude increased. These studies highlighted two 
important shortcomings in the control of alternans. First, given the spatiotemporal 
complexity of the heart, a 2D feedback system is essential to evaluate the spatiotemporal 
onset of alternans. Second, a major flaw in the control algorithms was the use of constant 
pacing cycle lengths or periodic stimulation. 
A new control algorithm that eliminated the dependence of DI on the preceding 
APD was implemented by Jordan and Christini [32] and shown to control alternans in a 1D 
Purkinje fiber in-silico study. Controlling the DI on a beat-by-beat basis ensures a dual 
purpose. First, constant DI ensures that the heart always gets enough time to relax at the 
end of an activation cycle. And second, it implies that the succeeding APD in every cycle 
is independent of any prior electrical irregularities. Control over the DI becomes even more 
critical in diseased hearts with diastolic dysfunction and impaired ventricular relaxation 
where periodic stimulation could further instigate electrical instabilities. Recently, the 
beneficial anti-arrhythmic effects of feedback elimination, by keeping the DI constant, in 
comparison to traditional periodic pacing were reported using single cell and 1D cable 
numerical simulations [12, 22]. Controlling and maintaining a Constant DI on a beat-by-beat 
basis, i.e. 
      DIn = DI = constant          (2) 
eliminated feedback and the inherent dependence of the DI on the preceding APD, which 
was successful in suppressing alternans [12, 22]. However, closed loop experimental 
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validation of beat-to-beat control of alternans has exhibited limited success, especially in 
2D cardiac tissue preparations [21, 31, 33, 34]. This is primarily since experimental 
implementation of Constant DI pacing is quite challenging and previous attempts involving 
the control of DI were limited to point sensing using microelectrodes, which failed to 
address the prevention of alternans in the heart. In order to precisely control the DI in the 
whole heart, on a beat-to-beat basis, there is a need to develop a sophisticated control 
algorithm that can sense an action potential in real-time based on comprehensive cardiac 
electrical information, and apply a stimulus after a predefined time interval at the end of 
the APD. 
An important focus of my research was to develop a real-time beat-to-beat control 
system to successfully implement Constant DI pacing and demonstrate its efficacy in 
suppressing alternans in the whole heart.  We successfully addressed the technical 
limitations mentioned previously and implemented a novel method to validate the anti-
arrhythmic benefits of feedback elimination using Constant DI, in ex-vivo isolated whole 
rabbit hearts using high resolution 2D optical mapping. The proposed algorithm opens the 
doors for the modulation of cardiac electrical activity in real-time, during various diseased 
states and abnormal rhythms. Successful validation of the anti-arrhythmic benefits of this 
pacing technique and its adaptation into a clinically viable device can radically improve 
the quality of life of patients suffering from diastolic dysfunction, impaired ventricular 
relaxation and abnormal cardiac rhythms. Crossing traditional boundaries and integrating 
research from multiple disciplines, this research holds promise in translating theoretical 
findings into a clinically useful therapeutic device. 
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2.6 Optical Mapping for Study of Cardiac Arrhythmias 
The field of cardiac electrophysiology has focused on gaining a better 
understanding of the electrophysiological properties of the healthy and diseased heart and 
the electromechanical coupling between cardiomyocytes and tissues to gain important 
insights into the mechanisms of life threatening cardiac arrhythmias, which can cause heart 
attacks or in extreme dangerous cases, sudden cardiac death. Optical mapping is a widely 
used technique in the preclinical research setting to study the electrical activity in the heart 
and cardiac cells in both healthy and diseased states. It’s an imaging modality that utilizes 
fluorescent dyes to look at physiological parameters (i.e. changes in membrane potential) 
at both high temporal and spatial resolutions. In the past 20 years, optical mapping has 
enhanced our understanding of complex arrhythmias and the electrophysiological 
remodeling that occurs during disease states. Furthermore, it has also aided in the 
development and evaluation of several therapeutic strategies and pacing protocols for the 
treatment of cardiovascular diseases [35-37]. 
Optical mapping enables recording the electrical activity (action potentials) from 
isolated whole mammalian hearts. Excised animal hearts are kept alive and beating ex-vivo 
using external perfusion. Voltage-sensitive dyes are injected into the heart and excited with 
the use of a laser. Optical movies corresponding to the emitted fluorescence signal are then 
recorded from the epicardial surface of the heart by fast, high resolution CCD cameras. 
Traditionally, optical mapping has been an ‘open loop’ technique wherein optical videos 
recorded during experiments are post processed to extract APD and other 
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electrophysiological information. Fig.2.7 shows a schematic of a typical optical mapping 
setup. 
Implementing and integrating a real-time beat-to-beat cardiac control algorithm 
with the existing optical mapping setup formed a critical aspect of my research. This was 
achieved by developing a novel control algorithm to detect T-waves from real-time ECG 
data on a beat-by-beat basis, integrated with conventional optical mapping. Fig.2.8 shows 
a schematic of the setup interfacing the real-time ECG based beat-to-beat control algorithm 
with high resolution optical mapping. 
Optical mapping has been widely used over the past decades to visualize, predict 
and control the onset of abnormal cardiac rhythms, such as alternans. It provides a unique 
opportunity to visualize and quantitatively assess the spread of electrical activity by 
recording action potentials simultaneously from multiple locations in both normal cardiac 
rhythms and arrhythmic episodes. The use of optical mapping to extract specific 
electrophysiological information and assess data is described separately for each study in 
the following chapters, based on the application. 
 
Figure 2.7: Schematic of open loop optical mapping setup 
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Figure 2.8: Schematic of the optical mapping system for real-time closed loop control of 
alternans. Red arrows highlight the real-time ECG T-wave detection and Constant DI 
algorithm implementation. Black arrows indicate 2D optical imaging and implementation 
of Periodic pacing. 
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CHAPTER 3: SPATIAL DYNAMICS OF BIFURCATION TO 
ALTERNANS 
 
(The work in this chapter was published in Kanchan Kulkarni, Ramjay Visweswaran, 
Xiaopeng Zhao, and Elena G. Tolkacheva, “Characterizing Spatial Dynamics of 
Bifurcation to Alternans in Isolated Whole Rabbit Hearts Based on Alternate Pacing,” 
BioMed Research International, vol. 2015, Article ID 170768, 8 pages, 2015. 
doi:10.1155/2015/170768) [38] 
 
Author Contributions: 
Concept was developed by E.G.T. and X.Z. Pacing protocol was implemented by K.K. 
based on previous theoretical work published by X.Z. Optical mapping experiments were 
designed by K.K. and E.G.T. and implemented by K.K and R.V. Data was analyzed by 
K.K. and prepared for publication by K.K. and E.G.T. 
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Abstract  
Sudden cardiac death instigated by ventricular fibrillation (VF) is the largest cause 
of natural death in the USA. Alternans, a beat- to-beat alternation in the action potential 
duration, has been implicated as being pro-arrhythmic. The onset of alternans is mediated 
via a bifurcation, which may occur through either a smooth or a border-collision 
mechanism. The objective of this study was to characterize the mechanism of bifurcation 
to alternans based on experiments in isolated whole rabbit hearts. High resolution optical 
mapping was performed and the electrical activity was recorded from the left ventricle 
(LV) epicardial surface of the heart. Each heart was paced using an “alternate pacing 
protocol,” where the basic cycle length (BCL) was alternatively perturbed by ±𝛿. Local 
onset of alternans in the heart, BCLstart, was measured in the absence of perturbations (𝛿 
= 0) and was defined as the BCL at which 10% of LV exhibited alternans. The influences 
of perturbation size were investigated at two BCLs: one prior to BCLstart (BCLprior = BCLstart 
+ 20 ms) and one preceding BCLprior (BCLfar = BCLstart + 40 ms). Our results demonstrate 
significant spatial correlation of the region exhibiting alternans with smooth bifurcation 
characteristics, indicating that transition to alternans in isolated rabbit hearts occurs 
predominantly through smooth bifurcation.  
3.1 Introduction 
Ventricular fibrillation (VF), manifesting as chaotic unsynchronized electrical 
activity in the heart, is known to cause sudden cardiac death (SCD). SCD is one of the 
largest natural causes of death, killing more than 300,000 people annually in the United 
States [39, 40]. Alternans has been implicated as being pro-arrhythmic and a potential source 
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of cardiac instability [1-4]. Electrical restitution can cause the heart to bifurcate from a 
constant APD response at lower frequencies to an alternating long-short APD pattern 
(alternans) at higher frequencies [13-15]. Characterizing this bifurcation can provide useful 
insights into understanding the dynamics of the cardiac system. In particular, knowledge 
of the bifurcation type that governs the transition to alternans can potentially be used as a 
means to predict the formation of alternans prior to their onset [41], which may be useful in 
preventing arrhythmias.  
Previous research has implicated both smooth and border-collision bifurcations 
when trying to characterize the transition to alternans in small cardiac tissue. Initially, 
Nolasco and Dahlen modeled transition to alternans as a smooth bifurcation [16]; however, 
later studies reported a border-collision type of bifurcation to alternans [42]. More recently, 
it was shown that a more complex bifurcation model involving the coexistence of both 
smooth and border-collision characteristics may exist in the heart. Based on experiments 
on adult bullfrog ventricular tissue samples, Berger et al. suggested the existence of a 
smooth-like behavior close to the bifurcation point and a border-collision type behavior 
further away from the bifurcation point [43]. Although the presence of different bifurcation 
characteristics in small tissue samples suggests very interesting dynamical behavior, their 
study was limited by the use of glass microelectrode recordings taken at single point 
locations. Therefore, the spatial distribution of the bifurcation characteristics and their 
correlation to alternans remains to be validated. 
The main objective of this study was to experimentally investigate the spatial 
dynamics of bifurcations that governs the transition to alternans in isolated whole rabbit 
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hearts. For this purpose, we applied an “alternate pacing protocol,” originally introduced 
by Heldstab et al. [44] and further experimentally investigated by Berger et al. [43]. 
Theoretical studies by Zhao et al. [45, 46] show that smooth and border-collision bifurcations 
to alternans demonstrate qualitatively different trends in their response to this alternate 
pacing protocol. We aimed to use this protocol to characterize the type of bifurcation to 
alternans and study its spatial distribution across the left ventricular (LV) surface of the 
heart. We also aimed to investigate the spatial correlation between the regions of the heart 
exhibiting alternans and the different bifurcation characteristics.  
3.2 Methods 
3.2.1 Optical Mapping 
All experiments were performed in accordance with the guidelines of the Institutional 
Animal Care and Use Committee at the University of Minnesota. New Zealand White 
rabbits (Bakkom Rabbitry, 1.3–2.0kg, 𝑛 = 4) were injected with heparin sulfate (550 U/100 
g) and anesthetized with ketamine and xylazine (35 mg/kg and 5mg/kg, resp.), as described 
previously [47, 48]. After a thoracotomy was performed, the heart was quickly removed and 
immersed in cardioplegic solution (in mM: glucose 280, KCl 13.44, NaHCO3 12.6, and 
mannitol 34). The aorta was quickly cannulated and retrogradely perfused with warm (37 
± 1∘C) oxygenated Tyrode’s solution (in mM: NaCl 130, CaCl2 1.8, KCl 4, MgCl2 1.0, 
NaH2PO4 1.2, NaHCO3 24, glucose 5.5, and pH 7.4) under constant pressure. The heart 
was immersed in a chamber and superfused with the same Tyrode’s solution. Blebbistatin 
(10 𝜇M) was added to Tyrode’s solution to reduce motion artifacts.  
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A bolus of 4 mL of the voltage-sensitive dye di-4-ANEPPS (10𝜇M) was injected and 
excited with the use of a diode- pumped, continuous-excitation green laser (532nm, 1W; 
Shanghai Dream Lasers Technology, Shanghai, China). Optical movies corresponding to 
the fluorescence signal were recorded from the epicardial surface of the LV by fast (1000 
frames per second) 14-bit resolution, 80 × 80-pixel resolution camera (Little Joe, RedShirt 
Imaging, SciMeasure) after a period of stabilization (∼30 minutes).  
3.2.2 Alternate Pacing Protocol 
External stimuli (5 ms duration, twice the threshold) were applied to the base of the 
LV surface of the isolated Langendorff-perfused rabbit hearts and the following alternate 
pacing protocol [43] was applied (see Fig.3.1).  
(1) Forty stimuli at a constant BCL (denoted by 𝐵0) value were applied to 
achieve steady state (SS).  
(2) Forty alternating stimuli were applied at BCL𝑛 = 𝐵0+ (−1) 𝛿, where 𝛿 = 5 
ms is the perturbation amplitude.   
(3) Steps (1) and (2) were repeated for 𝛿 values of 10, 15, and 20 ms, 
respectively. 
The baseline BCL 𝐵0 was progressively reduced from 300 ms down to 160 ms in steps of 
20 ms. Optical movies were acquired to capture the responses to last ten stimuli during 
Steps (1) and (2) for each BCL. The alternate pacing protocol was repeated twice for each 
heart, so a total of 8 protocols were analyzed across all hearts.  
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3.2.3 Data Analysis 
At each baseline BCL 𝐵0, APD was measured at 80% repolarization for each pixel. 
The APD responses for the last ten stimuli captured were divided in pairs and the amplitude 
of alternans was calculated as the absolute difference between even and odd APD 
responses: ΔAPD = |APDeven − APDodd|. The average amplitude of alternans was calculated 
across all five pairs, and the temporal threshold for APD alternans was set at 5ms. Two- 
dimensional (2D) alternans maps corresponding to SS responses (see Fig.3.2) were 
generated for the LV surface for each baseline BCL and were used to identify the local 
spatial onset of alternans (BCLstart) in the heart as described previously [47]. Specifically, 
BCLstart was identified as the SS 𝐵0 at which at least 10% of the LV surface exhibited 
Figure 3.1: Schematic of the alternate pacing protocol for a specific BCL B0. Grey 
boxes indicate responses that have been captures during optical mapping experiments. 
Local onset of alternans was calculated bases in steady state (SS) responses at δ = 0, 
while alternans induced by perturbations was calculated based on responses captured 
at increasing δ values. 
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alternans. The baseline BCL 𝐵0 just prior to BCLstart was denoted by BCLprior, and the BCL 
preceding BCLprior was denoted by BCLfar. Furthermore, the alternans was identified as 
either spatially discordant or spatially concordant based on the presence or absence of 
alternans with opposite phases, respectively [49]. Alternans was considered as spatially 
discordant if at least 5% of the alternans exhibited had opposite phases. Table 3.1 shows 
the total number of either type of steady state alternans for BCLstart, as well as alternans 
induced by 𝛿 = 5 ms perturbations for BCLprior and BCLfar.  
 
At each pixel, an amplification Gain was calculated as described previously [14]:  
Gain = 
|&'()|*+ .            (1)  
Theoretical investigations in [45] demonstrate that the Gain versus 𝛿 relation exhibits a 
decreasing trend as 𝛿 increases for smooth bifurcation, whereas the Gain versus 𝛿 relation 
exhibits an increasing trend as 𝛿 increases for border- collision bifurcation. At each pixel, 
Table 3.1: Classification of spatial pattern of alternans as concordant or discordant 
alternans for BCLstart, BCLprior and BCLfar for all experiments. 
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Gain was calculated for each 𝛿 at BCLprior and BCLfar, respectively. Then, the dependence 
of Gain on 𝛿 was fitted using a linear curve at BCLprior and BCLfar, respectively. The 
correlation coefficient R-square was then calculated to evaluate the quality of fitting. For 
R-square > 0.4, a decrease or increase in Gain with 𝛿 was identified as smooth or border-
collision bifurcation, respectively. To account for experimental noise, a threshold of 0.07 
(or smaller) between consecutive Gain values was considered acceptable while 
determining the trend. The bifurcation was considered as undetermined if the R-square < 
0.4 or if the consecutive Gain difference > 0.07. All data are presented as mean ± standard 
error. Statistical comparisons between the three bifurcation types were performed using 
ANOVA (Origin Software, Northampton, MA, USA). Values of 𝑃 < 0.05 were considered 
statistically significant.  
3.3 Results 
3.3.1 Spatial Distribution of Bifurcation Characteristics 
First, we studied the local onset of SS alternans (Step (1) of alternate pacing protocol) 
and alternans that are induced by small perturbations 𝛿 (Step (2) of the alternate pacing 
protocol). Fig.3.2(a) shows a representative example of the 2D alternans maps generated 
for different baseline BCLs 𝐵0 at SS. Here, blue and red regions indicate the presence of 
spatially discordant alternans (see color bar for alternans phases) while the white regions 
indicate the absence of alter- nans. In this example, the local onset of alternans, BCLstart 
(red box), occurred at 160 ms since more than 10% of the LV was occupied by alternans 
at this BCL. Consequently, BCLprior and BCLfar (green and blue boxes) were identified as 
180 ms and 200 ms, respectively. Fig.3.2(b) shows 2D maps illustrating the development 
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of alternans induced by small perturbations 𝛿 that were applied at BCLprior and BCLfar. Note 
that alternans is spatially discordant for BCLprior and spatially concordant for BCLfar. At 
both BCLprior and BCLfar, we observed that the heart was more prone to the formation of 
alternans as the perturbation size 𝛿 was increased, which is indicated by the progressive 
increase in the red and blue color as 𝛿 increases.  
Figure 3.2: (a) Representative 2D alternans maps for SS BCLs showing the local onset of 
alternans at BCLstart (red box). Two prior BCLs, BCLprior and BCLfar, are also shown (green 
and blue boxes). (b) 2D alternans maps induced by perturbations δ at BCLprior and BCLfar. 
Color bar represents the amplitude of alternans. 
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It has been previously demonstrated, using numerical simulations [45], that bifurcation 
to alternans can be identified by looking at the changes in the amplification Gain as a 
function of 𝛿. Therefore, for each 𝛿 we constructed 2D Gain maps to investigate the spatial 
distribution of the changes in Gain. Fig.3.3(a) shows a representative example of 2D Gain 
maps that were generated for BCLprior from Fig.3.2(b), showing the spatial distribution of 
Gain for various 𝛿.  
Fig.3.3(b) illustrates three representative single-pixel examples from Fig.3.3(a) (#, 
Φ, and ∗) indicating the presence of different trends in Gain as a function of 𝛿. It has been 
shown previously that a decrease in Gain with increase in 𝛿 indicates the presence of 
smooth bifurcation (see pixel # in Fig.3.3(b)), while an increase in Gain with an increase 
in 𝛿 characterizes border-collision bifurcation (see pixel Φ in Fig.3.3(b)) [43, 45]. We also 
found that at some pixels the type of bifurcation could not be determined (see pixel ∗ in 
Fig.3.3(b)).   
Fig.3.3(c) shows a representative 2D bifurcation map demonstrating the spatial 
distribution of different bifurcations for panel (a). Here, the region in black corresponds to 
the area of the heart (60.7%) that went to alternans through smooth bifurcation, the region 
in blue indicates border- collision bifurcation (16.8%), and bifurcation type could not be 
determined for the region in red (22.5%). Therefore, our analysis suggests that the heart 
transitions to alternans predominantly through smooth bifurcation.  
Finally, we quantified the percentage of LV area of the heart with smooth, border-
collision and undetermined bifurcations. Fig.3.4 shows the average percentage of LV area 
for each type of bifurcation separately for BCLprior (Fig.3.4(a)) and BCLfar (Fig.3.4(b)) 
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calculated across all our experiments. As seen from Fig.3.4, at BCLprior, for both spatially 
concordant and discordant alternans, the percentage of LV area of the heart that exhibited 
smooth bifurcation was significantly larger in comparison to the one with border-collision 
and undetermined bifurcations. At BCLfar, this result was valid for the case of spatially 
Figure 3.3: (a) Representative 2D Gain maps as a function of δ calculated at BCLprior for 
example shown in Fig.3.2(b). (b) Single-pixel trends in Gain as a function of δ for the three 
representative pixels masked in panel (a). # represents smooth and ɸ represents border-
collision bifurcation. The type of bifurcation in pixel * cannot be identified. (c) 2D 
bifurcation map showing the spatial distribution of different bifurcations for panel (a).  
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concordant alternans but not for the spatially discordant alternans. Our results suggest that, 
just prior to the onset of alternans, we predominantly observe smooth bifurcation 
characteristics in the heart, irrespective of the spatial pattern of alternans.  
 
3.3.2 Spatial Correlation of Local Onset of Alternans with Bifurcation 
Characteristics 
We also investigated the spatial correlation of the regions exhibiting alternans with 
the different bifurcation characteristics. First, we studied the spatial correlation between 
the regions of SS alternans and the bifurcation characteristics. Figs.3.5(a) and 3.5(b) show 
representative examples of 2D bifurcation map generated at BCLprior (see Fig.3.3(c)) and 
the SS alternans map generated at BCLstart (see Fig.3.2(a)), respectively.  
Figure 3.4: (a) Mean bifurcation characteristics in % of LV surface in all experiments, 
calculated for spatially concordant and discordant alternans at (a) BCLprior and (b) BCLfar. 
* indicates significance of p<0.05 between smooth and border-collision bifurcations. # 
indicates significance of p<0.05 between smooth and undetermined bifurcations. $ 
indicates significance of p<0.05 between bifurcation types for concordant alternans. 
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The spatial superposition of these two maps is shown in Fig.3.5(c). Therefore, in Fig.3.5(c) 
the bifurcation characteristics (calculated at BCLprior) are only shown for spatial regions 
that exhibited alternans at the next BCL (i.e., BCLstart). The white regions in Figs.3.5(b) 
and 3.5(c) were excluded from the analysis, since no alternans was present there at BCLstart. 
Figs.3.5(d) and 3.5(e) show the average percentage of LV area that developed SS alternans 
with the bifurcation characteristics calculated across all our experiments at BCLprior and 
BCLfar, respectively. Since the spatial pattern of alternans developed at BCLstart did not 
always coincide with the spatial pattern of alternans induced by perturbation, it was 
Figure 3.5: (a) Spatial correlation of the local onset of SS alternans with bifurcation 
characteristics. (a) 2D bifurcation map calculated at BCLprior (see Fig.3.3c) (b) 2D SS 
alternans map calculated at BCLstart (see Fig.3.2a). (c) Correlation between bifurcation 
and SS alternans maps. Average % of smooth, border-collision and undetermined 
bifurcations from all experiments are shown for (d) BCLprior and (e) BCLfar. * indicates 
p<0.05 
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difficult to categorize the bifurcation characteristics in relation to spatially concordant or 
discordant alternans. However, as seen from the figure, the overall regions of SS alternans 
that coincided with smooth bifurcation characteristics were significantly higher than those 
coinciding with border-collision bifurcation, both at BCLprior and BCLfar. The data suggests 
that the regions of the LV that eventually develop alternans at SS show predominantly 
smooth bifurcation characteristics prior to the onset of alternans.  
Figure 3.6: (a) Spatial correlation of alternans induced by perturbation (at δ = 5ms) with 
bifurcation characteristics. (a) 2D bifurcation map calculated at BCLprior (see Fig.3.3c) 
(b) 2D alternans map at δ = 5ms calculated at BCLprior (see Fig.3.2b). (c) Correlation 
between these two maps. Average % of smooth, border-collision and undetermined 
bifurcations from all experiments are shown for (d) BCLprior and (e) BCLfar.  
  34 
Similar analysis was performed to investigate the spatial correlation between 
bifurcation characteristics and alternans induced by alternate pacing. Figs.3.6(a) and 3.6(b) 
show a representative example of 2D bifurcation map (see Fig.3.3(c)) and 2D alternans 
map at 𝛿 = 5 ms (see Fig.3.2(b)), respectively. Note that both maps were calculated at 
BCLprior. Fig.3.6(c) shows the spatial correlation between these two maps. Figs.3.6(d) and 
3.6(e) show the average data across all experiments for BCLprior and BCLfar, for both 
spatially concordant and discordant alternans. As seen from the figure, the region of 
induced alternans coincided predominantly with smooth bifurcation characteristics, both at 
BCLprior and BCLfar, irrespective of the type of alternans. Note that the percentage of 
border-collision bifurcation is negligible. The data suggests that alternans that is induced 
by small perturbations is formed predominantly through smooth bifurcation.  
Comparison of data across Figs.3.5 and 3.6 suggests a higher spatial correlation 
between smooth bifurcation characteristics and alternans induced by perturbation as 
opposed to SS alternans. The induced alternans showed lower border-collision and 
undetermined characteristics than SS alternans at both BCLprior and BCLfar.  
3.4 Conclusion and Discussion 
We observed that the transition from constant APD response to alternans in isolated 
whole rabbit hearts occurred primarily through a smooth bifurcation. There was significant 
spatial correlation of the region exhibiting alternans with smooth bifurcation 
characteristics. The correlation of smooth bifurcation with alternans induced by 
perturbation was significantly higher than with SS alternans. As we moved away from the 
onset of alternans, the percentage of the heart exhibiting smooth bifurcation characteristics 
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decreased as the region with undetermined bifurcation characteristics increased. The region 
of the heart exhibiting border-collision bifurcation characteristics was significantly smaller 
than both the smooth bifurcation and the undetermined bifurcation regions.  
Characterizing the type of bifurcation to alternans holds promise as a possible 
method for the prediction of alternans prior to its onset and may shed light for the 
prevention of arrhythmias. In this study, we experimentally investigated the spatial 
dynamics of bifurcation that governs the transition to alternans in isolated whole rabbit 
hearts. We identified the local onset of alternans, characterized the bifurcation type prior 
to its onset, and studied the spatial distribution of bifurcation characteristics across the LV 
surface of the heart. In addition, we also investigated the spatial correlation of the regions 
of the LV exhibiting alternans with the type of bifurcation. To the authors’ best knowledge, 
this is the first study to investigate the bifurcation type of alternans based on spatial 
dynamics and quantify the spatial correlation of alternans with the type of bifurcation 
exhibited.  
Our main results are as follows. First, the bifurcation to alternans in the heart occurs 
predominantly through smooth bifurcation. Second, the region of the heart eventually 
exhibiting alternans shows a significantly higher spatial correlation to the region exhibiting 
smooth bifurcation characteristics.  
Previous studies attempted to characterize the bifurcation to alternans based on 
theoretical models of the atrioventricular nodes [42] or microelectrode recordings from 
ventricular tissue samples [43]. Here, we aimed to investigate the spatial distribution of the 
bifurcation characteristics by performing high resolution optical mapping experiments on 
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isolated whole rabbit hearts. Although initially described as a period doubling smooth 
bifurcation, later studies of alternans showed the existence of border-collision bifurcation 
characteristics and a more complex behavior that governed the transition to alternans. Our 
results indicated a spatial predominance to smooth bifurcation when transitioning from 
constant APD response to alternans in the LV region of the heart. Although the presence 
of border-collision bifurcation was seen, the region of the LV exhibiting smooth bifurcation 
was significantly higher.  
We also investigated the spatial correlation of the regions of the LV exhibiting 
alternans with the type of bifurcation in the case of both spatially concordant and spatially 
discordant alternans. As was seen from the results, there was significantly higher spatial 
correlation between alternans induced by perturbation with smooth bifurcation 
characteristics. For the purpose of this study, we only considered alternans induced by a 
perturbation of 5ms when investigating the spatial correlation between the induced 
alternans and the type of bifurcation. Since, as shown in the results, increasing the 
perturbation resulted in an increase in the area of the LV exhibiting alternans, a perturbation 
of 5 ms was a good representation of the onset of induced alternans. An interesting finding 
was that the regions of the LV that exhibited alternans at SS did not exactly coincide with 
the regions of the LV in which alternans was induced by perturbation. The phenomenon of 
spatial concordance or discordance of alternans also differed between SS and induced 
alternans. This can be attributed to the possibility that the alternate pacing protocol leads 
to altered dynamical activity of the heart compared to SS pacing. However, in both cases 
irrespective of the spatial pattern of alternans, just prior to the onset we see a significantly 
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higher spatial correlation of alternans with smooth bifurcation characteristics as compared 
with either the border-collision bifurcation or the undetermined bifurcation characteristics.  
Our results indicated that the region of the LV exhibiting border-collision 
bifurcation was significantly low while a definite portion of the LV exhibited undetermined 
characteristics. This indicates the possibility of the presence of other bifurcation 
characteristics in the heart with more complex behavior. However, in comparison to 
smooth bifurcation, the region with undetermined characteristics was still significantly 
smaller just prior to the onset of alternans, which supports the result that the transition to 
alternans predominantly occurs through a smooth bifurcation.  
  
  38 
CHAPTER 4: INCORPORATING STOCHASTICITY IN 
PERIODIC PACING 
 
(The work in this chapter was published in Kanchan Kulkarni, Steven Wallace Lee and 
Elena G. Tolkacheva, “Pro-arrhythmic effect of heart rate variability during periodic 
pacing,” 2016 38th Annual International Conference of the IEEE Engineering in Medicine 
and Biology Society (EMBC), Orlando, FL, 2016, pp. 149-152. doi: 
10.1109/EMBC.2016.7590662) s 
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Abstract  
Clinically, healthy hearts have been associated with a high ventricular HRV while 
diseased hearts have been known to exhibit low ventricular HRV. Hence, low HRV is 
suggested to be a marker of cardiac ventricular arrhythmias. Over the past few years, there 
has been considerable amount of interest in incorporating HRV in pacing to emulate 
healthy heart conditions and re-stabilize the electrical activity in diseased hearts. Recently, 
we used single cell numerical simulations to demonstrate that HRV incorporated into 
periodic pacing promotes alternans formation and thus, can be pro-arrhythmic. Here, we 
performed high-resolution optical mapping experiments on Langendorff perfused, healthy 
whole mice hearts to validate our numerical findings. Our results indeed demonstrate that 
HRV promoted the onset of cardiac alternans, which is believed to be a precursor of fatal 
cardiac rhythms. Hence, our present study suggests that incorporating HRV into periodic 
pacing while addressing several clinical needs may not be safe. There is a pressing need to 
better understand paced cardiac dynamics and develop anti-arrhythmic pacing techniques 
that would prevent cardiac arrhythmias.   
4.1 Introduction 
HRV is a physiologically inherent variation in time interval between two heart beats 
[23, 51, 52]. This variability is modulated by many physiological factors, including the 
influence of circadian rhythms, temperature regulations, changes in cardiac sympathetic 
and parasympathetic nerve activity, respiratory rhythms, etc. It is clinically well established 
that in a normal sinus rhythm, a high standard deviation in the HR signal correlates with 
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healthy cardiac tissue. In contrast, low HRV has been consistently reported to correlate 
with increased propensity of lethal cardiac arrhythmias [8-11].  
Previous studies have investigated the relationship between HRV and the formation 
of cardiac alternans. There has been considerable curiosity to investigate the effect of 
incorporating HRV in pacing in order to emulate healthy heart behavior in diseased hearts. 
However, previous in-silico studies elucidating the effect of HRV in periodic pacing have 
shown mixed results [12, 53-56]. Dvir et al. have reported that stochastic pacing increases 
electrical stability and the appearance of APD alternans [53-55]. Contrary to their results, 
McIntyre et al. reported that increased HRV promoted the formation of cardiac alternans 
during periodic pacing [12].  
Here, in a preliminary study, we aimed to experimentally demonstrate the effect of 
incorporating HRV in periodic pacing, on the formation of alternans in ex-vivo isolated 
mice hearts. Investigating the onset of alternans would provide an indication of the 
likelihood of the heart to transition into abnormal rhythms.  
4.2 Methods 
4.2.1 Optical Mapping 
All experiments conformed to the Guide for the Care and Use of Laboratory Animals 
(NIH publication No. 85-23, revised 1996) and the University of Minnesota guidelines 
regulating the care and use of animals. Wild type (WT, n=2) and a mixed strain (FVB129 
and C57B6) and genotype (CamKII Cre-::GIRK2FLox) background transgenic (TG, n=3) 
mice of either sex were used.  
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Mice were euthanized and hearts were quickly extracted through thoracotomy. 
Immediately upon removal, the hearts were immersed in cold cardioplegic solution (in 
mM: glucose 280, KCl 13.44, NaHCO3 12.6, and mannitol 34). The aorta was then quickly 
cannulated and perfused (retrograde) with warm (37±1°C) oxygenated Tyrode’s solution 
(in mM: NaCl 130, CaCl2 1.8, KCl 4, MgCl2 1.0, NaH2PO4 1.2, NaHCO3 24, glucose 
5.5, and pH 7.4). The hearts were immersed in a chamber and superfused with the same 
Tyrode’s solution.  
After 30 minutes of stabilization, voltage-sensitive dye (di- 4-ANEPPS, 5µg/mL; 
Molecular Probes, USA) was added to the perfusate. Two 532 nm diode continuous green 
lasers (SDL-532-1000 T, Shanghai Dream Lasers Tech, Shanghai, China) were used to 
illuminate the left ventricular (LV) surfaces of the heart. Fluorescence signals from more 
than 80% of total ventricular surface were captured with two 14-bit charge-coupled device 
(CCD) cameras (Little Joe, RedShirt Imaging, SciMeasure), that ran synchronously at 1000 
frames per second with 80 x 80 pixel resolutions. Blebbistatin (10 - 15 µM) was added to 
the Tyrode’s solution to stop heart contractions and reduce motion artifacts.  
4.2.2 Pacing Protocols 
The periodic pacing protocol is described by the following equation:  
APDn + DIn = BCL0            (1)  
where APDn is the APD generated by the nth stimulus, DIn is the nth diastolic interval (DI), 
and the baseline basic cycle length, BCL0, is the time interval between two consecutive 
stimuli. When HRV is absent (0% HRV), all BCLs are the same; and HRV can be modeled 
by modifying the BCL = BCLHRV as the following:  
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BCLHRV = BCL0 + (HRV)           (2)  
where δ(HRV) is a random number with a mean of zero and a standard deviation 
HRV*BCL0, and HRV is defined as:  
HRV = -)..'/0.. ∗ 100%            (3)  
where SDRR and AVGRR are the standard deviation and average of the RR intervals, i.e. 
distance between RR peaks on the mice ECG, respectively. HRV was set as 6% and 12%, 
based on HR and HRV information obtained during sinus rhythm from ex-vivo 
Langendorff perfused mice hearts (see Results).  
Experimentally, external stimuli (5 ms) duration, twice the activation threshold) were 
applied to the base of the LV using a periodic pacing protocol. The pacing protocol 
consisted of applying 100 stimuli at each BCL. The WT mice were paced from 140 ms 
down to 60 ms in steps of 20 ms, while the TG mice were paced from 130 ms down to 60 
ms in steps of 10 ms. Optical mapping movies corresponding to the last 10 stimuli were 
recorded at the end of each BCL in order to record steady state responses from the LV 
epicardial surfaces of the heart. Optical movies were recorded for 0% HRV, 6% HRV, and 
12% HRV from each heart. The WT mice hearts did not respond to pacing at lower BCLs 
even at 0% HRV and hence, those BCLs were not included in the data analysis.  
4.2.3 Data Analysis 
Recorded optical mapping movies were processed offline using custom software 
based on PV-wave (Visual Numerics, Inc.). The background fluorescence was subtracted 
from each frame, and spatial (3 x 3 pixels) and temporal (5 pixels) convolution filters were 
used. The optical APD were measured for each pixel at 80% repolarization (APD80), and 
  43 
two-dimensional (2D) APD maps were constructed to reveal distributions of APDs on the 
LV epicardial surface (Fig.4.3). Mean APD80 values were obtained at different BCLs by 
averaging APDs from all pixels.  
Alternans was calculated as a difference in mean APDs between two consecutive 
beats (B1 and B2):  
∆APD = |APDB1 − APDB2| ≥ 5 ms          (4)  
All APD variations smaller than the temporal threshold of alternans (5 ms) were defined 
as 1:1 responses. 2D ∆APD maps were constructed to reveal the distribution of alternans 
for the LV epicardial surfaces of the heart (Fig.4.3). The presence of alternans was denoted 
in red, and the presence of 1:1 behavior (absence of alternans) was denoted in black. The 
temporal onset of alternans, BCLonset, was defined as the BCL at which the temporal 
threshold (≥ 5ms) of alternans is met first. Statistical comparisons between mice exhibiting 
alternans at 0%, 6%, and 12% HRV were performed using Fisher’s exact test. Values of p 
< 0.05 were considered statistically significant. 
4.3 Results 
Table 4.1: HRV during sinus rhythm. Average (AVGRR) and standard deviation (SDRR) of 
RR interval, with HR and HRV calculated from captured ECG during sinus rhythm for 
three mice. 
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We first characterized the HRV of extracted Langendorff perfused whole mice 
hearts to approximate the range of HRV to be utilized during periodic pacing. Table 4.1 
summarizes the HR and HRV information gathered from three mice. Based on the 
acquired data, two values of HRV were chosen: 6% and 12%.  
Fig.4.1 shows representative bifurcation diagrams depicting the change in APD80 
with decreasing BCL0, for 0%, 6% and 12% HRV. As seen from Fig.4.1, HRV promoted 
the onset of alternans since BCLonset was preponed with increasing values of HRV. Fig.4.2 
Figure 4.1: Bifurcation diagrams showing change in APD with BCL for (A) 0%, (B) 6^ 
and (C) 12% HRV. BCLonset indicates onset of alternans. (D) Illustrative examples of action 
potential traces showing 1:1 behaviour vs alternans. 
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quantifies the number of mice that exhibited alternans for different values of HRV. Note 
that we combined both WT and TG mice together. Fig.4.2 demonstrates that the number 
of mice exhibiting alternans increased with an increase in HRV. Based on Fisher’s exact 
test, a significantly higher number of mice exhibited alternans at 12% HRV, as compared 
to periodic pacing with 0% HRV.  
Representative 2D APD maps for two consecutive beats, B1 and B2, along with 
corresponding alternans maps are shown in Fig.4.3 for different values of HRV. The 
BCLonset is highlighted with yellow squares. Fig.4.3 indicates that the temporal onset of 
alternans occurs earlier as HRV is increased. The individual values of BCLonset at different 
% of HRV are shown in Fig.4.4. Note that as HRV is increased, the hearts exhibited 
alternans earlier, thus becoming more susceptible to arrhythmias. Only one TG mouse 
(TG2) exhibited alternans at 0% HRV.  
 
Figure 4.2 Quantification of mice that developed alternans. # indicates statistical 
significance of p<0.05 between 0% and 12% HRV. 
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4.5 Conclusion and Discussion 
The objective of this study was to elucidate the effect of introducing HRV into 
periodic pacing, on the onset of cardiac alternans. We have two main results from our 
experiments: (1) Incorporation of HRV in periodic pacing promoted the onset of alternans, 
and (2) The onset of alternans preponed with increase in HRV. Therefore, our data suggest 
that HRV is pro-arrhythmic when combined with periodic pacing.  
Figure 4.3 2D APD maps showing spatial distribution of APD for two consecutive beats 
B1 and B2 along with alternans maps for decreasing BCL. 
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Here, we study alternans as an indicator to investigate the proclivity of the heart to 
transition into unstable electrical rhythms. Although the mice model typically does not 
exhibit alternans under normal physiologic conditions due to the short value of APD, here 
we had a dual purpose of using this model. First, as we expect to see no alternans in WT 
mice at 0% HRV, it was interesting to investigate if increase in HRV instigated the onset 
of alternans. Our results support this finding, as indeed increase in HRV induced alternans 
in WT mice. Furthermore, Fig.4.1C highlights an interesting phenomenon. We see the 
temporal onset of alternans at BCL = 120 ms, while alternans do not seem to appear at 
BCL = 100 ms. Temporal alternans reappear at the subsequent lower BCLs. This could be 
due to the formation of spatially discordant alternans which are not captured in average 
temporal activity, thus emphasizing the spatiotemporal complexity of alternans. 
Figure 4.4 Change in BCLonset with increase in HRV for each mouse 
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Second, we also looked at transgenic mice which, due to altered ionic conditions, had 
the possibility of exhibiting alternans at 0% HRV. In this case, we saw that the onset of 
alternans was further preponed with an increase in HRV. Hence, irrespective of the 
underlying ionic compositions, our data suggests that incorporation of HRV in periodic 
pacing can have pro-arrhythmic effects.  
Here, we investigated the effect of incorporating HRV in periodic pacing, wherein 
there is a fixed relation between APD and DI (Eq.1). Our results suggest that HRV further 
instigates instability in cardiac rhythm during periodic pacing, leading to the proposition 
that feedback elimination rather than feedback modulation might be essential in preventing 
cardiac alternans. A more detailed spatio-temporal assessment of the effects of feedback 
on the onset of alternans is presented in the next chapter. 
One of the limitations of this study was that it only considered the temporal onset of 
alternans. We applied 100 stimuli at each BCL to reach steady state. Hence, we hypothesize 
that consecutive beats would be an adequate measure of average APD. However, alternans 
is known to be a spatial phenomenon that develops gradually across the whole heart [57]. In 
this preliminary study, we aimed to only investigate the temporal onset of alternans. Further 
investigative studies would be required to compare the spatial dynamics.  
In conclusion, we experimentally investigated the effect of incorporating HRV in 
periodic pacing by performing high-resolution optical mapping experiments on isolated 
whole mice hearts. Our data suggests that irrespective of underlying ionic compositions, 
increased HRV shows pro-arrhythmic effects during periodic pacing. HRV in periodic 
pacing promotes the formation of cardiac alternans and the onset of alternans is preponed 
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with increase in HRV. Hence, our present study suggests that simply incorporating HRV 
in pacing may not be safe clinically. There is a pressing need to better understand paced 
cardiac dynamics and develop anti-arrhythmic pacing techniques that would prevent 
cardiac arrhythmias.  
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CHAPTER 5: FEEDBACK ELIMINATION USING 
CONSTANT DIASTOLIC INTERVAL PACING 
 
(The work in this chapter has been accepted for publication as Kanchan Kulkarni, Steven 
Wallace Lee, Ryan Kluck and Elena G. Tolkacheva, “Real-Time Closed Loop Diastolic 
Interval Control Prevents Cardiac Alternans in Isolated Whole Rabbit Hearts”, Annals of 
Biomedical Engineering, Nov 7th, 2017) 
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Abstract 
Cardiac alternans, a beat-to-beat alternation in action potential duration (APD), is 
a precursor to fatal arrhythmias. During periodic pacing, changes in diastolic interval (DI) 
depend on subsequent changes in APD, thus enhancing cardiac instabilities through 
‘feedback’ mechanism. Recently, an anti-arrhythmic Constant DI pacing protocol was 
proposed and shown to be effective in suppressing alternans in 0D and 1D in-silico studies. 
However, experimental validation of Constant DI in the heart has been unsuccessful due 
to the spatio-temporal complexity of 2D cardiac tissue and the technical challenges in its 
real-time implementation. Here, we developed a novel closed loop system to detect T-
waves from real-time ECG data, enabling successful implementation of Constant DI, and 
performed high-resolution optical mapping experiments on isolated whole rabbit hearts to 
validate its anti-arrhythmic effects. The results were compared with: (1) Periodic pacing 
(feedback inherent) and (2) pacing with heart rate variability (HRV) (feedback modulation) 
introduced by using either Gaussian or Physiological patterns. We observed that Constant 
DI significantly suppressed alternans in the heart, while maintaining APD spatial 
dispersion and flattening the slope of the APD restitution curve, compared to traditional 
Periodic pacing. In addition, introduction of HRV in pacing failed to prevent cardiac 
alternans, and was arrhythmogenic.  
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5.1 Introduction 
Fatal arrhythmias and ventricular fibrillation (VF) which lead to sudden cardiac 
death are believed to be preceded by alternans. APD alternans often manifest as T-wave 
alternans, an alternation in the shape or duration of the T-wave, in an electrocardiogram 
(ECG). Previous studies have established a plausible link between alternans and ventricular 
arrhythmias, suggesting that elimination of alternans could lead to the prevention of VF 
and eventual arrhythmias in the heart [3, 5-7]. Over the past two decades, several groups have 
attempted the control of alternans through in-silico, in-vitro and ex-vivo experiments [6, 12, 
21, 22, 28-34]. Although early studies reported positive results in single cell models and in-
vitro preparations [29, 30], control of alternans in more spatiotemporally complex two-
dimensional (2D) settings proved unsuccessful [21, 31].  
This can be attribute to a major flaw in the control algorithms, i.e. the use of 
periodic stimulation:  
APDn + DIn = BCLn = BCL= constant                             (1) 
During periodic pacing (Eq.1), there is a partial dependence of the DI on the preceding 
APD (DIn= BCL - APDn), i.e. feedback, that can lead to subsequent destabilization of 
normal cardiac rhythms [15, 25]. We recently reported the drawbacks of periodic pacing using 
single cell and 1D cable numerical simulations [12, 22], in comparison to the beneficial anti-
arrhythmic effects of feedback elimination by keeping the DI constant, i.e. 
      DIn = DI = constant          (2) 
Controlling and maintaining a Constant DI on a beat-by-beat basis, eliminated feedback 
between DI and the preceding APD and was successful in suppressing alternans [12, 22]. 
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However, closed loop experimental validation of beat-to-beat control of alternans has 
exhibited limited success, especially in 2D cardiac tissue preparations [21, 31, 33, 34]. This is 
primarily due to the technical challenges in precisely controlling the DI on a beat-to-beat 
basis in real-time.  
The main goal of the current study was to develop a real-time beat-to-beat control 
system to successfully implement Constant DI pacing and demonstrate its efficacy in 
suppressing alternans in the whole heart.  We successfully addressed the technical 
limitations mentioned previously and implemented a novel method to validate the anti-
arrhythmic benefits of feedback elimination using Constant DI, in ex-vivo isolated whole 
rabbit hearts. Specifically, we implemented a closed loop algorithm to detect pseudo T-
waves from real-time ECG data on a beat-by-beat basis, measure real-time APD and apply 
stimuli after a predefined Constant DI. To our knowledge, this is the first study to use 
whole heart 2D optical mapping for high resolution spatio-temporal assessment of 
feedback between DI and APD. In addition, we compared the electrophysiological and 
anti-arrhythmic effects of Constant DI pacing with different pacing protocols. Namely, the 
following protocols were used: (1) Periodic (feedback inherent), (2) HRV pacing (feedback 
modulation), introduced by using both (2.1) Gaussian and (2.2) Physiological variability 
patterns, and (3) Constant DI (feedback eliminated).  
5.2 Methods 
5.2.1. Optical Mapping 
All experiments were performed in accordance with the guidelines of the Institutional 
Animal Care and Use Committee at the University of Minnesota. Optical mapping 
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procedures were performed as previously described [38, 57]. Briefly, New Zealand White 
rabbits (Bakkom Rabbitry, 1.3 – 2.0 kg, 𝑛=4) were injected with heparin sulfate (550 U/100 
g) and anesthetized with ketamine and xylazine (35 mg/kg and 5 mg/kg, resp.). The heart 
was quickly excised after a thoracotomy and immersed in cold cardioplegic solution (in 
mM: glucose 280, KCl 13.44, NaHCO3 12.6, and mannitol 34). The aorta was quickly 
cannulated and retrogradely perfused with warm (37 ± 1∘ C) oxygenated Tyrode’s solution 
(in mM: NaCl 130, CaCl2 1.8, KCl 4, MgCl2 1.0, NaH2PO4 1.2, NaHCO3 24, glucose 5.5, 
and pH 7.4) under constant pressure. The heart was immersed in a chamber and superfused 
with the same Tyrode’s solution. Motion uncoupler Blebbistatin (10 𝜇M) was added to 
Tyrode’s solution when needed to reduce motion artifacts.  
A bolus of 4 mL of the voltage-sensitive dye di-4-ANEPPS (10 𝜇M) was injected 
and excited with the use of a diode pumped, continuous-excitation green laser (532 nm, 1 
W; Shanghai Dream Lasers Technology, Shanghai, China). Optical movies corresponding 
to the fluorescence signal were recorded from the epicardial surfaces of the left and right 
ventricles (LV and RV) by fast (1000 frames per second) 14-bit resolution, 80 × 80-pixel 
resolution cameras (Little Joe, RedShirt Imaging, SciMeasure) after a period of 
stabilization (∼30 minutes). Simultaneously, continuous 3-electrode volume conducted 
ECG was recorded throughout the experiments.  
5.2.2. Real-time Closed Loop Control Algorithm 
Fig.5.1A shows a schematic of the setup interfacing the real-time ECG-based Constant DI 
control algorithm with high-resolution optical mapping. We utilized RT intervals on the 
ECG to approximate an APD, while TR interval was maintained constant to implement 
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Constant DI. However, as the correspondence between RT, TR intervals and APD, DIs 
respectively has been well established [12], fundamentally our method implements feedback 
Figure 5.1 (A) Schematic of the optical mapping system. Red arrows highlight the real-
time ECG T-wave detection and Constant DI algorithm implementation. Black arrows 
indicate 2D optical imaging and implementation of Periodic and HRV pacing. (B) 
Validation of Constant DI pacing using real-time ECG recording for representative target 
DI of 40 ms. Black arrows mark achieved Constant DI. (C) Error at each DI, calculated 
as difference between achieved and expected DI, for one representative pacing run. 
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elimination by controlling the repolarization interval. Arrows in black indicate the original 
optical mapping set up that was used for the Periodic and HRV pacing implementation. 
Arrows in red indicate the closed loop system that enables real-time T-wave detection from 
pseudo-ECG and implementation of Constant DI pacing. Constant DI pacing was 
implemented using a proprietary algorithm developed in LabVIEW that detected the ECG 
T-wave peak and applied a pacing stimulus after a predefined fixed duration equivalent to 
the required DI. 
5.2.3. Pacing Protocols 
The following pacing protocols were implemented: 
(1) Periodic pacing protocol. Since Periodic pacing (Eq.1) enforces the BCL to be 
constant during each beat, it creates an inherent dependency of the DI on the preceding 
APD, i.e. feedback. Hence, in this study, we refer to Periodic pacing protocol as 
‘feedback inherent’ protocol. 
(2) HRV pacing protocol. Under normal physiological conditions, intrinsic HRV, a 
variation in time interval between two consecutive heartbeats, ensures deviation of the 
heart from periodic pacing [23, 52]. To simulate known healthy human HRV and to in 
turn modulate the feedback between DI and APD, we incorporated stochasticity in 
pacing by varying the BCLs. Two different HRV pacing protocols were used to 
generate ‘feedback modulation’: 
(2.1) Gaussian pacing. Here, we incorporated HRV in pacing by using a strictly 
Gaussian distribution of beat-to-beat intervals. Gaussian pacing was implemented as 
follows: 
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BCLn = BCL0 ± δ(HRV)                                (3) 
where δ(HRV) is a random number with a mean of zero and standard deviation of 
BCL0*HRV, and,   
     HRV = 	 67899:;<99 ∗ 100	%         (4) 
where STDRR and AVGRR standard deviation and average of the RR intervals i.e. the 
distance between the RR peaks in the ECG. To mimic known human HRV values [12, 
58] we used a Gaussian distribution with HRV set at 5%.  
(2.2) Physiological pacing. Here, to mimic a physiological HRV pattern, we utilized 
the variation in RR intervals from a previously acquired anesthetized in-vivo rat ECG 
recording. The original HRV of 1.12% was scaled up to 5% to simulate a quasi-
physiologically relevant human HRV value, and the scaled RR ‘pattern’ was 
superimposed onto BCL values to implement Physiological pacing for each BCL from 
200 ms down to 120 ms in steps of 10 ms. 
(3) Constant DI pacing protocol. To evaluate the proposed anti-arrhythmic effects of 
‘feedback elimination’, we implemented Constant DI pacing as shown in Eq.2 
External stimuli at twice the activation threshold, were applied at the base of the LV for 
each rabbit, during each pacing protocol. 100 stimuli were applied at each BCL for 
Periodic and HRV pacing, and the BCL was progressively decreased from 200 ms down to 
120 ms in steps of 10 ms. Similarly during Constant DI, 100 stimuli were applied at each 
DI and the DI was progressively decreased from 100 ms down to 30 ms in steps of 10 ms.  
A total of n = 26 (9, 6, 5, 6) pacing runs were analyzed for the LV, while n = 20 (6, 
5, 5, 4) runs were analyzed for the RV, for the Periodic, Gaussian, Physiological and 
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Constant DI pacing protocols respectively. Runs of each pacing protocol were acquired in 
each rabbit in a random manner, to eliminate any effect of pacing order on the results. 
Optical movies corresponding to the last ten stimuli were recorded for each BCL (DI) for 
all pacing protocols.  
5.2.4. Data Analysis 
1. APD Alternans: Optical movies were recorded from the epicardial surfaces of 
both the LV and RV. Mean APD at 80% repolarization (<APD80>) was calculated for RV 
and LV for the even (APDEVEN) and odd (APDODD) beats separately. 2D mean APDEVEN 
and APDODD maps were generated for each BCL and DI. Temporal threshold for alternans 
was set at |APDEVEN - APDODD | ≤ 4 ms and 2D alternans maps were generated as a 
difference of mean APDEVEN and APDODD maps. For spatial onset of alternans, the BCL 
(or DI) at which at least 20% of the area of the RV or LV was occupied by alternans was 
defined as the BCLonset (or DIonset). The presence of spatial alternans was then quantified 
for all the pacing runs.  
2. APD Heterogeneity: To assess the dispersion of APD80 repolarization across the 
LV and RV surfaces, we calculated APD80 heterogeneity index µ as follows: 
µ = (APD95 – APD5) / APD50         (5)  
wherein, APD95 and APD5 represent the 95th and 5th percentiles of the APD80 distribution, 
respectively, and APD50 is the median APD80 distribution. For each BCL and DI, 
heterogeneity µ was calculated based on 2D APD maps generated for an average APD80 of 
3-5 beats. 
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 3. Comparison between BCL and DI: In order to compare data between the different 
pacing protocols, corresponding DI for each BCL was calculated for each Periodic and 
HRV pacing run as follows: 
DI = BCL – <APD80>           (6) 
wherein, for |APDEVEN - APDODD | ≤ 4 ms, the larger of the two APD values was used as 
<APD80> , while for BCLs where |APDEVEN - APDODD | > 4 ms, <APD80> = <(APDEVEN, 
APDODD)>. Finally, mean DI values corresponding to each BCL were calculated for the 
Periodic and HRV pacing protocols by combining DI values for individual runs. 
4. Slopes of APD Restitution Curve (Smax): To evaluate the effect of the different 
pacing protocols on the slope of APD restitution curve and in turn the propensity to 
arrhythmias, we calculated the minimum DI (DImin) for each pacing run (DI corresponding 
to the last BCL for each run). APD restitution curves were generated as a function of 
change in <APD80> with DI and fit with a 2nd degree polynomial. The maximum slope of 
restitution, Smax, was calculated for each run by evaluating the derivative of the polynomial 
fit at DImin. Finally the individual mean Smax values, corresponding to change in 2D 
<APD80>  with DI, for each pacing run were combined to generate average Smax values for 
each pacing protocol.  
5.2.5. Statistics 
All data are presented as mean ± standard error. Statistical comparisons between the pacing 
protocols were performed using 1-way ANOVA (Origin Software, Northampton, MA, 
USA). Fisher’s exact test was used to perform statistical comparison of the number of runs 
  60 
that exhibited arrhythmias across the different pacing protocols. Values of 𝑃 < 0.05 were 
considered statistically significant. 
5.3 Results 
1. Real-time T-wave measurements 
We first validated accurate T-wave detection by the real-time algorithm and execution of 
Constant DI pacing. The time instances of each T-wave peak detected and pacing stimulus 
applied was outputted by the algorithm for each run. Fig.5.1B shows representative real-
time ECG data collected during a Constant DI run. Two checks performed to demonstrate 
the successful implementation of Constant DI pacing. First, the difference between 
expected and achieved DI, i.e. algorithm error, was calculated and was < 8 ms across all 
experimental runs. Fig.5.1C displays the algorithm error quantified for all beats at each DI, 
for one representative Constant DI run. Second, for each DI, the ECG data acquired was 
also analyzed post experiment and the T-wave peak detected by the algorithm was 
compared to the visible T-wave peak on the ECG to ensure accurate detection (Fig.5.1B). 
Any run that incorrectly detected a T-wave or missed the expected DI by more than 10 ms 
was excluded from further analysis. 
2.  Presence and onset of alternans 
We quantified the number of pacing runs that exhibited alternans in the heart for each 
pacing protocol and the corresponding BCLonset. As seen in Fig.5.2A, Constant DI pacing 
significantly reduced the instances of cardiac alternans in the heart (only 1 run 
demonstrated the presence of alternans for DI = 40ms in the RV), compared to the other 
three pacing protocols. Periodic and HRV pacing always induced alternans along with 
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instances of VF during Gaussian and Physiological pacing. Furthermore, comparing 
BCLonset between the Periodic and HRV pacing techniques (Fig.5.2B), we observed that 
onset of alternans is promoted with an increase in stochasticity in pacing i.e. Physiological 
pacing showed the largest BCLonset (194 ± 2.67 ms), while Periodic pacing showed the 
smallest (137 ± 4.52 ms, p<0.05).  
3.  Spatio-temporal evolution of alternans 
Figure 5.2 (A) Quantification of the number of runs that exhibited alternans for each 
pacing technique, for both the LV and RV combined. Threshold for spatial onset of 
alternans = 20% area of LV or RV, temporal threshold = 4ms. (B) Comparison of 
BCLonset between Periodic, Gaussian and Physiological pacing. * denotes statistical 
significance of p < 0.05 
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Next, we quantified the spatial evolution of alternans for the different pacing protocols as 
a percentage of RV or LV, for decreasing values of DI. Since Physiological pacing 
Figure 5.3 Representative 2D APD maps for APDEVEN (B1), APDODD (B2) and ΔAPD 
(alternans), for (A) Periodic, (B) Gaussian and (C) Constant DI pacing, from the LV. 
Action potential traces depicting alternans (*) at lower BCL and no alternans (Δ) at higher 
BCL are shown for Periodic and Gaussian pacing. Note that no alternans were observed 
for Constant DI pacing and representative action potential traces at two distinct DIs are 
denoted by * and Δ. 
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significantly preponed BCLonset compared to both Gaussian and Periodic pacing, we only 
show data comparing Periodic, Gaussian and Constant DI from here on. Fig.5.3 shows 
representative 2D APDEVEN and APDODD maps along with 2D alternans maps for 
decreasing BCLs and DIs, for Periodic, Gaussian and Constant DI pacing. For both 
Periodic and Gaussian pacing, we observed an increase in the area of the heart occupied 
by alternans as we decreased the BCL (shown in terms of calculated corresponding DIs), 
Figure 5.4 Demonstrating the spatial evolution of alternans across the (A) LV and (B) RV 
with decreasing DIs, for Periodic (blue), Gaussian (red) and Constant DI (green) pacing 
techniques. Dotted black line indicates spatial threshold of 20% used to define BCLonset. 
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as demonstrated in Fig.5.4. Note that Constant DI pacing prevented the spatio-temporal 
evolution of alternans in both LV and RV.  
4.  APD Heterogeneity µ 
Fig.5.5 demonstrates the change in APD heterogeneity µ with a decrease in DIs for the 
three pacing protocols, along with representative 2D APD maps. We observed increased 
µ, suggesting a greater dispersion of APD repolarization, in the case of Gaussian pacing, 
compared to Periodic and Constant DI pacing, for both the LV and RV. The 2D APD maps 
shown for a DI of ~ 50ms demonstrated the increased heterogeneity induced by Gaussian 
Figure 5.5 Change in heterogeneity µ with decreasing DIs for Periodic (blue), Gaussian 
(red) and Constant DI (green) pacing, for both (A) LV and (B) RV. Representative 2D APD 
maps alongside for each pacing technique, demonstrating the distribution of APD80 across 
the ventricles for a calculated DI of ~ 50ms. 
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pacing. Comparatively, both Periodic and Constant DI showed relatively homogenous 
APD distributions for both the LV and RV.  
5.  APD Restitution Curve  
Fig.5.6 shows APD80 as a function of different DIs for Periodic, Gaussian and Constant 
DI protocols. As seen from the figure, at higher DIs we observed slightly larger APD80 
during Constant DI pacing. In case of the LV for instance, at DI = 60ms, APD80= 127.30 
± 5.5ms  (equivalent BCL = ~190ms). In comparison, for BCL = 190ms, APD80= 119.39 
± 2.8ms for Periodic pacing and APD80= 120.48 ± 2.5ms for Gaussian pacing, which was 
not significantly different. However, Constant DI pacing significantly lowered Smax in 
comparison to other pacing protocols, in both the LV and RV. It is important to note that 
both Periodic and Gaussian pacing had Smax >1 for both LV and RV, while Smax <1 during 
Constant DI pacing, demonstrating its anti-arrhythmic effect. In addition, the calculated 
DImin for the Gaussian pacing was significantly larger compared to both Periodic and 
Constant DI pacing for the LV (Fig.5.6 bottom panel). 
5.4 Discussion 
Here, we extended our previous in-silico findings of the anti-arrhythmic benefits of 
Constant DI [12, 22] pacing to the whole heart level and implemented a novel real-time closed 
loop system for beat-by-beat cardiac control. Using our system, we investigated the effect 
of feedback on the propensity to cardiac alternans, using three different pacing protocols: 
Periodic (feedback inherent), HRV (feedback modulation) and Constant DI (feedback 
elimination). Our major findings are as follows: First, we successfully implemented an 
algorithm for real-time detection of T-waves and validated its efficacy in controlling the 
  66 
DI on a beat-to-beat basis in the heart. Second, Constant DI pacing prevented the 
occurrence of alternans in the heart, thus providing a clear anti-arrhythmic effect. Constant 
Figure 5.6 Data shown for (A) LV (left panel) and (B) RV (right panel). Top: Restitution 
curves demonstrating change in mean APD80 with decreasing DIs for Periodic (blue), 
Gaussian (red) and Constant DI (green) pacing. Mid: Mean restitution slopes Smax 
calculated at DImin. Bottom: Mean DImin across all runs. * denotes statistical significance 
of p < 0.05 and # denotes statistical significance of p < 0.07. 
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DI pacing was associated with an increase in APD and decrease in Smax, while not affecting 
spatial heterogeneity of APD, µ, in comparison to Periodic pacing.  
On the other hand, feedback modulation using HRV pacing, which was modeled 
with either Gaussian or in-vivo Physiological patterns, promoted the formation of alternans 
and VF in the heart, thus enhancing arrhythmogenecity. HRV pacing was associated with 
both increased Smax and µ, and earlier occurrence of alternans (larger BCLonset), in 
comparison to Periodic pacing, thus providing clear pro-arrhythmic effects.  
 Our results support our hypothesis that the presence of feedback, or dependence of 
the DI on the preceding APD, can lead to electrical instability and cardiac arrhythmias, 
especially at higher pacing rates. This was demonstrated by the onset of spatio-temporal 
cardiac alternans during all Periodic pacing runs. Feedback modulation or HRV further 
perturbed the stability of the system and promoted arrhythmogenesis.  To incorporate HRV 
in pacing, we used two methods. Gaussian distribution with 5% HRV was used to 
introduce perturbations in BCL, based on previously shown human HRV values and 
distributions [15, 19]. Furthermore, to investigate a truly ‘random’ yet physiological 
perturbation, we also implemented quasi-Physiological pacing by utilizing RR interval 
patterns from previously recorded in-vivo rat ECG traces. However, our results 
demonstrated an increase in arrhythmogenecity during HRV pacing, with Physiological 
pacing showing earlier onset of alternans than Gaussian pacing. This can be attributed to 
the fact that incorporating HRV in pacing only modulates feedback and does not eliminate 
the dependence of the DI on prior perturbations. Constant DI pacing however, ensures that 
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the DI during each beat is independent of any prior instabilities or perturbations in the APD 
and hence, is more electrically stable. 
 HRV pacing also showed an increase in APD heterogeneity compared to both 
Periodic and Constant DI pacing. Since the beat-to-beat intervals are varied randomly 
when incorporating HRV in pacing, it is possible that APD repolarization is 
heterogeneously affected. While certain regions might fully repolarize, other regions might 
be forced to reactivate before complete repolarization, which eventually could lead to 
heterogeneity in APD distribution across the surface of the heart. This could lead to 
abnormal activations such as early after depolarizations (EADs) and delayed after 
depolarizations (DADs), which are known to be arrhythmogenic. This is supported by our 
data wherein we see earlier onset of alternans, instances of VF and an earlier loss of pacing 
response (conduction block) during HRV pacing, demonstrated by a significantly larger 
DImin in case of the LV. 
 Constant DI pacing also demonstrated a flattening in the slope of restitution. 
Numerous studies have suggested the anti-arrhythmic effects of flattening the restitution 
slope [7, 29, 59]. Expectedly, our data showed significantly steeper restitution curves during 
Periodic and HRV pacing, wherein we see an onset of alternans. Since Constant DI pacing 
aims to maintain a fixed DI during each heartbeat, we see an almost linear decrease in APD 
as we shorten our target DI, again demonstrating the beneficial effects of feedback 
elimination. Overall, our data shows promising anti-arrhythmic effects of feedback 
elimination and beat-to-beat DI control. Furthermore, all of our findings were consistent 
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between the LV and RV and we did not observe any significant differences in terms of the 
anti-arrhythmic benefits of Constant DI pacing, between the two ventricles. 
Note that there are two main limitations of the study. First, we utilized volume 
conducted 3-electrode ECG that was easy to integrate with existing 2D ex-vivo optical 
mapping system, to implement Constant DI pacing. Hence, our study is limited by the 
temporal resolution achieved by volume conducted ECG and observing a distinct T-wave. 
Given the rabbit model and ex-vivo setup, at very high pacing rates, the T-wave cannot be 
discerned, making it difficult to precisely detect the DI. However, feedback elimination 
can still be achieved by detecting a pseudo T-wave (post R-peak) and incorporating a time 
offset in the target DI. Hence, the minimum DI successfully implemented was 30 ms for 
our study. Second, we used healthy rabbit hearts for our study and hence, the size of the 
hearts limits the spatial validation of the pacing techniques. Further pre-clinical validation 
would be required to explore the benefits of Constant DI pacing in a large animal model, 
as well as under diseased conditions. However, since rabbits are known to have electrical 
and ionic characteristics similar to humans, we do not expect a change in model to 
significantly alter the concepts established in this study.  
In conclusion, we developed a novel real-time closed loop system to successfully 
validate the efficacy of Constant DI pacing in suppressing alternans using isolated whole 
hearts, hence demonstrating its potential in the prevention and control of cardiac 
arrhythmias. While the presence of feedback between the DI and APD, as demonstrated by 
use of Periodic pacing, induced cardiac alternans at higher pacing rates, incorporating HRV 
in pacing further enhanced the electrical instabilities and promoted the onset of alternans. 
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In addition, irrespective of the model used to incorporate HRV in pacing i.e. Gaussian or 
Physiological pattern, incorporating stochasticity in pacing showed pro-arrhythmic effects. 
Hence, our data suggests that feedback elimination using Constant DI might be essential 
in the prevention of restitution dependent cardiac alternans.  
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Abstract 
Introduction: A number of cardiac diseases have been linked to an imbalance in 
cardiac autonomic regulation and recently, there is rising interest in understanding the 
effect of parasympathetic modulation on cardiac dynamics. The main objective of our study 
is to investigate the role of the M2R-GIRK4-RGS6 parasympathetic pathway in ventricular 
electrophysiology, using isolated whole heart optical mapping of loss-of and gain-of 
parasympathetic function murine models. 
Methods and Results: We performed in-vivo ECG measurements and ex-vivo optical 
mapping experiments on wild-type (WT), Girk4 knockout (Girk4-/-) and RGS6 knockout 
(Rgs6-/-) mice.  The effect of muscarinic agonist carbachol (CCh), which mimics 
parasympathetic activation, was studied in all three genotypes. Our data suggests that an 
imbalance in parasympathetic function affects both cardiac structural and 
electrophysiological properties. We observed a prolongation in APD80 at baseline in both 
Girk4-/-and Rgs6-/-. The Rgs6-/- mice showed an enlargement in heart size and severe 
bradycardia post CCh injection. The CCh led to an increase in APD80 in WT, had a reduced 
effect in Girk4-/-, and an enhanced effect in Rgs6-/- mice. There was no significant effect of 
either Girk4 or RGS6 knock out on conduction velocity and APD heterogeneity. 
Conclusions: The muscarinic receptor mediated GIRK channel plays an important 
role in modulating ventricular electrophysiology. While Rgs6-/- enhanced parasympathetic 
function, Girk4-/- led to a loss-of parasympathetic function. Rgs6-/- made the heart more 
prone to arrhythmias, prolonged ventricular APD80 and enlarged heart size. Girk4-/-showed 
increased baseline HR and was more resistant to parasympathetic stimulation.  
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6.1 Introduction 
A number of cardiac diseases such as hypertension and chronic heart failure have 
been linked to an imbalance in cardiac autonomic regulation wherein there is an increased 
sympathetic overdrive and a withdrawal of parasympathetic activity [60-63]. Contrary to 
initial belief that cardiac parasympathetic nerves are mainly localized to the atria, in 
particular the sino-atrial (SA) and atrio-ventricular (AV) nodes, in the past decade studies 
have suggested a greater role of parasympathetic innervation in ventricular physiology [64-
67]. Recently, significant interest has been placed in investigating the efficacy of vagus 
nerve stimulation (VNS) as a therapy for metabolic and cardiovascular diseases. Multiple 
studies have reported beneficial effects of VNS in restoring autonomic imbalance by 
parasympathetic activation of the heart [68-71]. One hypothesis is that stimulation of the 
vagal nerve fibers innervating the ventricles can lead to positive remodeling of the heart 
and be used in the treatment of cardiovascular diseases such as hypertension and 
myocardial ischemia. However, despite the rising interest in parasympathetic modulation 
of the heart, the underlying mechanisms and ionic effects of activation of the ventricular 
vagal fibers remain unknown.  
It has been established that the parasympathetic modulation of the heart is mediated 
by the muscarinic M2 receptors, which activate the G-protein coupled inwardly rectifying 
potassium (K+) channels (GIRK) [72, 73]. The M2R receptors in cardiac myocytes activate 
G-proteins upon binding to acetylcholine (ACh). Subsequently, the activated G-protein can 
bind to GIRK causing an increased K+ efflux (IkACh). Hence, the release of ACh by 
activation of the vagus nerve causes an increased IkACh via the GIRK channels that are 
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composed of the GIRK1 and GIRK4 subunits. This results in membrane hyperpolarization, 
reduced action potential (AP) firing and correspondingly, a reduced heart rate (HR). 
Regulator of G-protein signaling (RGS) proteins negatively regulate G protein signaling 
thereby having an inhibitory effect on the GIRK channels, promoting their deactivation 
and increasing repolarization time [74-76]. Out of multiple RGS proteins, RGS6 has been 
specifically implicated in regulation of GIRK function and shown to play an essential role 
in cardiac parasympathetic activation [74-76]. However, given the common dogma that 
parasympathetic innervation and control of the heart is restricted to the SA and AV nodes, 
most studies have investigated the influence of the M2R-GIRK-RGS6 pathway in atria. 
With rising evidence for parasympathetic innervation of the ventricles [64-67], there has been 
interest in characterizing the role this parasympathetic pathway plays in ventricular 
electrophysiology. A more recent study demonstrated the presence of the GIRK4 channels 
in cardiac ventricles across different species, suggesting an important contribution of the 
GIRK channels in parasympathetic control of the ventricles [72-74].  
The main objective of our study is to investigate the role of the M2R-GIRK4-RGS6 
parasympathetic pathway in ventricular electrophysiology through loss-of and gain-of 
parasympathetic function mice models. We first evaluate structural remodeling effects of 
ablating GIRK4 (loss-of parasympathetic function) and RGS6 (gain-of parasympathetic 
function) by quantifying heart weight variances based on age, gender and genotype. 
Furthermore, we aim to determine the influence of GIRK4 and RGS6 modulation of 
parasympathetic function on ventricular electrophysiology, independent of any structural 
remodeling, using in-vivo ECG measurements and ex-vivo optical mapping.  
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6.2 Materials and Methods 
All experiments were performed in accordance with the guidelines of the 
Institutional Animal Care and Use Committee at the University of Minnesota. Genetically 
modified Girk4-/- and Rgs6-/- mice models were created as previously described [76, 77]. Mice 
were divided into three groups (see Table 6.1): wild type (WT) mice as control; Girk4 
knockout mice (Girk4-/-) with ablated IkACh Girk4 subunit; and RGS6 knockout mice 
(RGS6-/-) without the RGS6 protein. We first characterized any cardiac structural 
remodeling effects of ablating either GIRK4 or RGS6 in two age groups, 65 - 95 days and 
> 130 days postnatal (P). We then performed in-vivo and ex-vivo cardiac 
electrophysiological measurements in P65-95 mice to assess electrical characteristics 
independent of any structural effects.  
1. Heart size measurements 
We characterized the heart weight (H.W.) based on age and gender for all three mice 
genotypes. For each mouse, a quick thoracotomy was performed, the heart was excised and 
perfused with phosphate buffered saline (PBS) to flush out all the blood before the H.W. 
was measured. The tibia was harvested and its length (T.L.) was measured.  The H.W. 
normalized by T.L. which remains constant after mouse maturity, was used to quantify 
heart sizes.  
2. In-vivo ECG measurements 
Mice were anesthetized with ketamine and xylazine (35 and 5 mg/kg, respectively) and 
ECG recordings were performed using IX-ECG recorder interfaced with Labscribe 
software. After 20 minutes of stabilization period, 10 minutes of baseline ECG was 
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recorded. Then, 300 nM of carbachol (CCh) was administered via a tail vein injection. The 
final concentration of CCh was estimated using approximated blood volume based on body 
weight of each mouse measured at the beginning of the experiment. After a 5 minute 
waiting period for the CCh to reach equilibrium, 10 minutes of ECG was recorded post 
CCh injection. The 10 minute baseline and post-CCh intervals of ECG recordings were 
used to calculate heart rate (HR), HR variability (HRV) and identify the arrhythmic 
episodes. Any noise artifacts were removed through data filtering and only clean segments 
of ECG data were used. A maximum HR threshold was set to 1000 bpm for baseline and 
mean baseline HR + 25 bpm for evaluating effect of CCh, in order to eliminate artefacts 
and erroneous spikes in HR. HRV was calculated as a ratio of standard deviation of HR to 
mean HR. Number of mice that exhibited arrhythmic episodes post injection of CCh were 
also quantified. An arrhythmic episode was defined as an occurrence of either bradycardia 
(at least 25 bpm < mean post CCh HR) or tachycardia (at least 25 bpm > post CCh HR) 
that lasted for over a 2 second duration.   
3. Ex-vivo optical mapping experiments 
Isolated ex-vivo whole heart optical mapping experiments were performed as previously 
described [38, 50, 57]. To exclude any structural remodeling effects that may be induced by 
mouse age and sex differences, P65-95 mice of either sex were used for Rgs6-/-, whereas 
predominantly male mice were used for WT and Girk4-/- (see Table 6.1 and Fig. 6.1). 
Briefly, mice were first heparinized to avoid blood clots during heart excision. Ketamine 
and xylazine (100 mg/kg and 10 mg/kg, respectively) was administered to anesthetize the 
animal following which hearts were quickly excised and immersed in cold cardioplegic 
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solution (in mM: glucose 280, KCl 13.44, NaHCO3 12.6, and mannitol 34). The aorta was 
isolated under microscope for cannulation and the hearts were retrogradely perfused with 
warm (37±1°C) Tyrode’s solution (in mM: NaCl 130, CaCl2 1.8, KCl 4, MgCl2 1.0, 
NaH2PO4 1.2, NaHCO3 24, glucose 5.5, and pH 7.4) using Langendorff perfusion setup. 
After 15 minutes of stabilization, a bolus of the voltage sensitive dye, di-4-ANEPPS, 5 
µg/mL was injected into the hearts. Two green lasers (532 nm, Shanghai Dream Lasers 
Tech., Shanghai, China) were used to excite the hearts and the fluorescence signal emitted 
was recorded from the left ventricular (LV) surface by a fast high resolution (14-bit, 80x80 
pixels, 1000 frames/s) CCD camera (Little Joe, RedShirt Imaging, SciMeasure). 
Mechanical uncoupler Blebbistatin (10 µM) was added to the perfusate to reduce motion 
artifacts when required. Background fluorescence was eliminated during analysis by using 
spatial (3 x 3 pixels) and temporal convolution filters. 
 The hearts were paced at progressively decreasing basic cycle lengths (BCL), 
starting from 150 ms down to 60 ms in steps of 10 ms. At each BCL, 40 stimuli were 
applied to reach steady state, and optical movies corresponding to the last 10 stimuli were 
recorded and later analyzed. After capturing baseline recordings, hearts were injected with 
a bolus of CCh, either 300 nM (n = 5, 4 and 4 for WT, Rgs6-/- and Girk4-/- respectively) or 
3 µM (n = 3 and 3 for WT and Girk4-/- respectively). After 10 minutes of stabilization, 
similar pacing protocol was repeated and optical movies were captured.  
4. Ex-vivo parameter measurements 
Optical movies were analyzed to characterize the electrophysiological properties of the 
LV. The action potential duration (APD) was calculated at 80% (APD80) repolarization. 
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For each mouse, average of 5 action potentials was used to calculate mean APD80 at each 
pixel. Two dimensional (2D) APD maps were then constructed as described previously [50, 
57] to demonstrate the spatial distribution of APD. For each heart and at each BCL, average 
APD value for the entire LV surface was then calculated from individual pixel values. To 
investigate the dispersion of repolarization in LV, APD80 heterogeneity was calculated 
based on the heterogeneity index µ as, 
µX = (X95 - X5) / X50  
where X is APD80, X95 and X5 represent the 95th and 5th percentiles of the APD80 
distribution, and X50 is the median of the APD80 distribution. Conduction velocity (CV) 
was calculated as described previously [57]. Specifically, the distributions of activation 
times measured at (dV/dt)max for the spatial regions of 3 x 3 pixels were fitted with the 
plane, and gradients of activation times were calculated for the each plane. The magnitude 
of the local CV was calculated for each pixel. APD restitution curves were generated by 
plotting mean APD80 as a function of mean diastolic interval (DI = BCL – APD80). The 
maximum slope of APD restitution, Smax, was calculated by fitting with 2nd degree 
polynomial and evaluating its derivative at the lowest DI value for each run. Mean Smax 
was then calculated for each genotype both at baseline and post administration of CCh. 
5. Statistics: 
All data are presented as mean ± standard error. Statistical comparisons between the three 
genotypes were performed using 1-way ANOVA (Origin Software, Northampton, MA, 
USA). Since there was no statistical difference between the baseline APD80 values for the 
300 nM and 3 µM CCh groups, a single combined baseline was used. Comparison of 
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dosage dependent CCh and baseline data was then performed using 1-way ANOVA. 
Fisher’s exact test was used to perform statistical comparison of the number of mice that 
exhibited arrhythmias across the three mice groups. Values of 𝑃 < 0.05 were considered 
statistically significant.  
6.3 Results 
1. Structural remodeling of loss-of and gain-of parasympathetic function: 
We first investigated the structural differences between the three mouse genotypes 
considering both sex and age (see Fig.6.1). In P65-95 Girk4-/- mice (Fig.6.1A), loss of 
parasympathetic function led to a significant decrease in the heart size, compared to both 
WT and Rgs6-/- hearts (p < 0.05). In contrast, there was only a moderate increase in heart 
size of P65-95 Rgs6-/- mice. However, this heart size increase in P>130 Rgs6-/- mice became 
significant (p < 0.05, Fig.6.1C). To further elucidate if the heart size differences between 
the genotypes were sex dependent, we compared heart sizes between males and females 
for each group. As seen in Fig.6.1B, there was a significant difference in the P65-95 male 
and female heart sizes within each knockout mice genotype, which was absent in WT mice. 
The overall reduction in young Girk4-/- mice heart size seemed predominantly due to 
smaller female Girk4-/- mouse hearts (Fig.6.1B). Female WT hearts were significantly 
larger in size compared to Girk4-/- females. The difference in P>130 WT and Rgs6-/- mice 
hearts also seemed to be predominantly due to larger female Rgs6-/- hearts than female WT 
mice hearts (Fig.6.1D). Overall, the results suggest that ablation of RGS6 protein led to an 
enlargement in heart size which enhanced with aging, while Girk4-/- led to a reduction in 
heart size. The heart size differences between the knock out mice and WT were mainly due 
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to differences in female hearts. Hence, for our ex-vivo optical mapping experiments, to 
eliminate any structural remodeling effects, we used young mice, with a mix of males and 
females for Rgs6-/- and predominantly male WT and Girk4-/- mice. 
Figure 6.1 Characterization of heart sizes: (A) Comparison of heart sizes (H.W. / T.L.) in 
young WT, RGS6-/- and Girk4-/- mice. ‘*’ denotes statistical significance of p < 0.05 
between Girk4-/- and both WT and RGS6-/-. (B) Gender dependent comparison of WT, 
RGS6-/- and Girk4-/- mice. ‘#’ denotes statistical significance of p < 0.05 between WT and 
Girk4-/- female mice, ‘*’ denotes statistical significance of p < 0.05 between male and 
female mice for the same genotype. (C) Comparison of heart sizes in old WT and RGS6-/- 
mice. ‘*’ denotes statistical significance of p < 0.05. (D) Gender dependent comparison of 
heart sizes in old WT and RGS6-/- mice. ‘#’ denotes statistical significance of p < 0.05 
between female mice, ‘*’ denotes statistical significance of p < 0.05 between male and 
female mice for the same genotype. 
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2. In-vivo effect of parasympathetic modulation. 
Fig.6.2A, B presents HR and HRV data for WT, Girk4 and RGS6 mice at baseline and 
after parasympathetic stimulation with 300 nM CCh. Fig.6.2A demonstrates that at 
baseline, Rgs6-/- showed a significantly lower HR compared to both WT and Girk4-/- mice, 
but HRV showed no significant difference between the three genotypes. Parasympathetic 
stimulation by injection of 300 nM CCh led to a significant drop in HR for both the WT 
and Rgs6-/- mice compared to their respective baselines, while there was no significant 
change in HR for the Girk4-/- mice. In addition, CCh significantly increased HRV in WT 
and Rgs6-/- mice, which correlated with an increased number of mice exhibiting 
arrhythmias in these two groups (Fig.6.2B, C). Fig.6.2D shows representative examples of 
bradycardia and tachycardia episodes in WT and Rgs6-/-. 
3. Ex-vivo optical mapping assessment of loss and gain of parasympathetic function: 
1. Effect on action potential duration. We investigated the changes in baseline 
APD80 as a result of ablating either Girk4 or RGS6 compared to WT mice. Fig.6.3A 
displays the change in LV APD80 with decrease in BCL for the three genotypes at baseline. 
As seen in the figure, mice lacking Girk4 show a prolongation in baseline APD80, in 
comparison to WT mice. Rgs6-/- mice had prolonged APD80 at higher BCLs. Representative 
2D APD80 maps along with action potential traces for the three genotypes during baseline 
and post injection with CCh, at a BCL of 120 ms are shown in Fig.6.3B. The action 
potential traces demonstrate a larger APD80 at baseline for both Girk4-/- and Rgs6-/- CCh 
stimulation significantly increased APD80, and the effect was dose dependent, as shown in 
Figs.6.3C-E. Since 3 µM CCh led to a loss of HR response in Rgs6-/- mice, only 300 nM 
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CCh dosage was used in these mice, which led to a significant elongation in APD80. Girk4-
/- mice show a shunted effect of parasympathetic stimulation compared to WT mice, 
exhibiting a significant prolongation in APD80 only at a high CCh dosage of 3 µM.  
#
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Figure 6.2 In-vivo ECG measurements: Comparison of (A) HR and (B) HRV, between WT, 
Girk4-/- and Rgs6-/- mice at baseline and post injection of 300 nM CCh. ‘*’ denotes 
statistical significance of p < 0.05 between baseline and 300 nM CCh within the same 
genotype. ‘&’ denotes statistical significance of p < 0.05 for both baseline and 300 nM 
CCh across genotypes. ‘#’ denotes statistical significance of p < 0.05 between WT and 
Rgs6-/- mice at 300 nM CCh; ‘$’ denotes statistical significance of p < 0.05 between Girk4-
/-  and Rgs6-/- mice at 300 nM CCh. (C) Quantification of the total number of mice that 
exhibited arrhythmias post injection of 300 nM CCh. ‘*’ denotes statistical significance of 
p < 0.05 between Girk4-/- and Rgs6-/-. (D) Representative examples of ECG data 
highlighting episodes of arrhythmia in WT and Rgs6-/- post injection of CCh, and  no 
arrhythmia in Girk4-/-  mice. 
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2. Slopes of restitution Smax. Administration of CCh increased the slopes of 
restitution in all the three genotypes as demonstrated by Fig.6.4. For WT and Girk4-/-, we 
observed a dose dependent effect of parasympathetic stimulation, with 3 µM CCh leading 
to significantly larger Smax. Rgs6-/- had the most apparent effect of parasympathetic 
overdrive and showed steepening of restitution slopes with 300 nM CCh stimulation. 
Figure 6.3 Ex-vivo optical mapping data: Effect on APD80 (A) Change in average APD80 
with decreasing BCLs for each genotype at baseline. ‘#’ denotes statistical significance of 
p < 0.05 between WT and Girk4-/-. ‘$’ denotes statistical significance of p < 0.05 between 
WT and Rgs6-/-. (B) Representative 2D APD80 maps for all 3 genotypes, at a BCL of 120ms 
both at baseline and post CCh injection. Representative action potential traces shown at 
baseline (top panel, pixels marked by *) and demonstrating effect of CCh (bottom panel, 
pixels marked by Δ). (C-E) Effect of CCh on APD80 for WT, Girk4-/- and Rgs6-/- respectively. 
‘*’ denotes statistical significance of p < 0.05 between baseline and 300 nM CCh; ‘&’ 
denotes statistical significance of p < 0.05 between baseline and 3 uM CCh. 
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3.Effect on conduction velocity and APD80 heterogeneity. Fig.6.5A shows the 
change in LV CV with decreasing BCL for the three genotypes at baseline. There was no 
difference in the CV values across the genotypes at baseline. No significant effect of 
parasympathetic stimulation using CCh was observed in any of the genotypes (Figs.6.5C-
E). Fig.6.5B shows representative activation maps demonstrating smooth propagation of 
action potentials for all the three groups both at baseline and post CCh.  
 
The change in LV APD80 heterogeneity for the three mice groups with decreasing 
BCL at baseline is shown in Fig.6.6A. No significant differences in heterogeneity was 
observed between the three mice groups, both at baseline and post injection of CCh 
(Figs.6.5B-D). 
Girk4-/- RGS6-/- 
Figure 6.4 Comparison of the effect of CCh on the slopes of restitution Smax, in WT, Girk4-
/- and Rgs6-/- mice. ‘*’ denotes statistical significance of p < 0.05 between post CCh and 
baseline for the same genotype. 
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6.4 Discussion 
It is well established that the autonomic nervous system (ANS) plays an important 
role in regulating cardiac electrical activity. Both branches of the ANS, namely the 
sympathetic and parasympathetic systems, directly innervate the heart and influence 
cardiac electrophysiology. While a stimulation of the sympathetic system increases cardiac 
contractility, HR and conductivity, stimulation of the parasympathetic system has an 
opposite effect. Under diseased conditions such as hypertension and chronic heart failure, 
we see an imbalance in autonomic activity [60-63]. However, the effects of modulating the 
Figure 6.5 Ex-vivo optical mapping data: Effect of CV (A) Change in average CV with 
decreasing BCLs for each genotype at baseline. (B) Representative 2D activation maps for 
all 3 genotypes, at a BCL of 150ms both at baseline and post CCh injection. (C-E) Effect 
of CCh on CV for WT, Girk4-/- and Rgs6-/- respectively. 
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ANS on cardiac electrical activity remain confounding due to a lack of understanding of 
the existence and function these pathways play in cardiac electrophysiology. Here, we 
aimed to investigate the effect of modulating the known M2R mediated GIRK 
parasympathetic pathway on ventricular electrical activity. Using specific knock out 
models for GIRK4 and RGS6, we confirm the definite role of this pathway in modulating 
murine ventricular physiology. We also show that an imbalance in parasympathetic 
function (using loss-of and gain-of function models) affect both cardiac structural and 
electrophysiological properties.  
 Our major findings are as follows: (1) Ablation of GIRK4 and RGS6 can lead to 
structural remodeling in the heart. (2) Parasympathetic stimulation of Girk4-/- and Rgs6-/- 
Figure 6.6 Ex-vivo optical mapping data: Effect on heterogeneity (A) Change in average 
heterogeneity index µ with decreasing BCLs for each genotype at baseline. (B-D) Effect of 
CCh on heterogeneity index µ for WT, Girk4-/- and Rgs6-/- respectively. 
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mice leads to a dose dependent prolongation in APD80 and steepening of APD restitution. 
(3) The M2R- GIRK4-RGS6 pathway plays an important role in modulating ventricular 
electrophysiology and overall cardiac dynamics.  
In-vivo ECG and Structural Effects:  
Our in-vivo ECG data displayed a significant difference in baseline HRs across the three 
groups (Fig.6.2). As expected in Girk4-/- mice, ablation of the GIRK4 led to a loss-of 
parasympathetic function, leading to a slightly higher baseline HR compared to WT. On 
the other hand, ablation of RGS6 led to a gain-of parasympathetic function model, 
demonstrated by a significant decrease in baseline HR. Rgs6-/- mice also had the most 
pronounced effect of parasympathetic stimulation using CCh. Since RGS6 plays an 
inhibitory role of reducing IkACh, ablation of RGS6 led to an increase in parasympathetic 
activation and drop in baseline HR. Further stimulation with CCh led to a parasympathetic 
overdrive and severe bradycardia in these hearts. The electrical instability created by 
parasympathetic overdrive is also depicted in the large HRV post CCh injection and the 
onset of arrhythmias in Rgs6-/- hearts. WT hearts showed a modest drop in HR as an effect 
of parasympathetic stimulation by CCh, while in Girk4-/- mice we saw a shunted effect of 
parasympathetic activation with no significant drop in HR. This can be attributed to a 
reduced IkACh in Girk4-/- mice, leading to a withdrawal of parasympathetic function. 
 Interestingly, we a saw a difference in heart sizes between the three genotypes. 
Rgs6-/- mice had significantly enlarged hearts, while Girk4-/- mice had a reduction in heart 
size compared to WT (Fig.6.1). This suggests that a chronic imbalance in parasympathetic 
function, specifically an overdrive of parasympathetic activity could lead to structural 
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remodeling of the heart. While there is prior evidence of the role of RGS6 in protecting 
against cardiac ischemic injury and aiding tumor suppression [78-80], a more detailed study 
would be needed to corroborate our current findings. However, our preliminary data show 
evidence of a gender and age dependent effect of parasympathetic overdrive on cardiac 
size. 
Ex-vivo Results: 
To characterize the role of the M2R-GIRK4-RGS6 pathway in ventricular 
electrophysiology, we analyzed APD80, CV and the heterogeneity index µ. We observed a 
prolongation in APD80 at baseline in Girk4-/- and Rgs6-/- mice. Since GIRK4 is a critical 
subunit contributing to IkACh, the observed effect of its ablation on ventricular 
repolarization can be attributed to a loss of this current in these mice. Rgs6-/- mice showed 
a prolongation in APD80 only at certain higher BCLs with a sharp drop in APD80 at lower 
BCLs, highlighted by the larger Smax. This supports prior evidence of the arrhythmogenic 
effects of RGS6 ablation [74, 81]. Although previous studies have investigated the effect of 
RGS6 ablation on atrial APD [74-76], their role and impact on ventricular electrophysiology 
is relatively unknown. This is the first study to investigate the effect of RGS6 ablation on 
electrical restitution and characterize its effect on ventricular APD at different pacing rates. 
Our results strongly indicate that RGS6 does play an important role in ventricular 
repolarization via direct modulation of IkACh. 
 Parasympathetic stimulation using CCh showed a significant increase in APD80 in 
WT mice. CCh has been shown to decrease APD in healthy hearts and isolated atrial 
myocytes previously [82-85] mediated by an activation of IkACh. However, there has been 
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contradictory evidence provided showing an increase in APD with vagal stimulation [86-88]. 
Furthermore, since CCh is a non-selective cholinergic agonist, it can lead to activation of 
both nicotinic and muscarinic receptors. As nicotinic receptors are known to mediate 
cholinergic neurotransmission, CCh could stimulate both sympathetic and parasympathetic 
post-ganglionic neuronal activity. Indeed, it has been shown that the anti-fibrillatory effects 
of vagal stimulation occur via post-ganglionic efferent nerve fibers independent of 
muscarinic receptor activation [88, 89]. Hence, the increase in ventricular repolarization seen 
in WT mice could be attributed to the combined effect of both nicotinic and muscarinic 
receptors activation. We see a reduced effect on APD80 in the loss-of parasympathetic 
function model (Girk4-/-) while an enhanced effect in the gain-of parasympathetic function 
model (Rgs6-/-). However, in all three genotypes, CCh increased the slopes of restitution, 
with the biggest effect observed in Rgs6-/-. An increased restitution slope is hypothesized 
to be pro-arrhythmic with prior studies claiming that onset of arrhythmias can occur when 
the magnitude of restitution slope exceeds one [7, 13]. Rgs6-/- had the maximum slope of 
restitution post injection of CCh. This supports the in-vivo data wherein parasympathetic 
overdrive caused an increase in arrhythmic episodes in Rgs6-/- mice.  
Due to the complex interplay between the sympathetic and parasympathetic 
receptors in conjunction with possible electrical remodeling in the knock out mice, it is 
difficult to attribute the effect of CCh stimulation on the whole heart ventricular 
repolarization to a specific current or protein. However, it is apparent that both GIRK4 and 
RGS6 play a role in modulating ventricular repolarization. There was no significant effect 
of either Girk4 or RGS6 knock out on conduction velocity or heterogeneity (Figs.6.4 and 
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6.5). Since conduction velocity is predominantly affected by sodium channel activity, a 
lack of significant effect of IkACh on ventricular conduction was not surprising.  
  In summary, our data provides evidence supporting the role of parasympathetic 
innervation on murine ventricular physiology. We establish that the M2R-GIRK4-RGS6 
pathway plays an important role in modulating ventricular repolarization. While Rgs6-/- 
enhances parasympathetic function, Girk4-/- leads to a loss-of parasympathetic function 
model. These loss-of (Girk4-/-) and gain-of (Rgs6-/-) parasympathetic function models could 
help better understand the effects of autonomic imbalance and parasympathetic modulation 
on cardiac function and ventricular electrophysiology. In addition, by developing atrial and 
ventricular specific knock out models, we can investigate the specific contributions of IkACh 
in regulating APD and identify possible atrial components indirectly affecting ventricular 
signaling. Furthermore, by using nicotinic blockers and suppressing sympathetic 
activation, we can isolate the effect of parasympathetic stimulation on APD. However, 
given the complex interplay between the sympathetic and parasympathetic systems, it is 
essential to understand the global electrophysiological responses in the whole heart as a 
result of possible autonomic imbalance. Hence, in this study we aimed to characterize 
cardiac electrical function in both a loss-of and gain-of parasympathetic function model. 
Overdrive of parasympathetic system (Rgs6-/-) made the heart more prone to arrhythmias, 
severe bradycardia, excessive HRV, prolongation of ventricular APD80 and possible 
enlargement of heart. Diminished parasympathetic system (Girk4-/-) was more resistant to 
parasympathetic activation, showed increased baseline HR and needed an increased dosage 
of parasympathetic stimulant to equal WT characteristics. These findings could be a basis 
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for further studies exploring the role of autonomic innervation on ventricular 
electrophysiology. 
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Measurement WT (n) RGS6-/- (n) Girk4-/- (n) Age (days) Gender 
Heart Size 
6 8 7 65-95 Male 
5 5 6 65-95 Female 
4 6 - >130 Male 
7 6 - >130 Female 
In-vivo ECG 
5 4 4 65-95 Male 
3 4 2 65-95 Female 
Optical Mapping 
7 2 8 65-95 Male 
1 3 - 65-95 Female 
Total (n) 38 38 27   
 
Table 6.1. Summary of mice used for experiments 
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CHAPTER 7: DISCUSSION AND FUTURE WORK 
 
This research targeted multiple aspects in the study of predicting and preventing the onset 
of cardiac alternans. It required application of engineering principles from non-linear 
dynamics and feedback control systems along with fundamentals of cardiac 
electrophysiology, to develop novel techniques for suppressing alternans. The main 
accomplishments of this research are: 
1) Development of a novel real-time closed loop algorithm for beat-to-beat cardiac control 
based on ECG detection, 
2) Successful implementation of feedback elimination using Constant DI pacing and 
validation of its beneficial anti-arrhythmic effects using ex-vivo isolated whole hearts, 
3) Highlighting the importance of feedback elimination as opposed to feedback modulation 
using stochastic pacing, 
4) Implementing a pacing technique to induce alternans and conclusively characterizing 
the transition from steady state to alternans as smooth bifurcation, and 
5) Characterizing the effects of modulating the parasympathetic pathways on cardiac 
dynamics and ventricular electrophysiology. 
The concepts established in this research have the potential for clinical translation and with 
further preclinical validation could be a source for improving the current treatment 
strategies for cardiac arrhythmias. 
7.1 Clinical Translation of Constant DI 
  93 
Here, we performed a comprehensive study of different pacing techniques, based 
on the foundation that feedback between DI and APD is inherently pro-arrhythmic. We 
used the onset of alternans as an indication of the stability of the heart by investigating its 
proclivity to transition into abnormal rhythms. Expectedly, we established the resistivity 
of constant DI pacing to the formation of alternans in the heart, thus suggesting the anti-
arrhythmic benefits of feedback elimination. 
These promising results could be the first step in the preclinical adaptation of 
constant DI pacing in a prototype pacemaker. The next step in translating this research into 
a clinically relevant therapeutic device, would be to perform experiments in a swine model 
to test the efficacy of constant DI pacing in-vivo. A swine model lays the foundation for 
smoother adaptability into potential future human studies. Positive reviews from clinicians 
during interactions at conferences where this research was presented, suggest optimistic 
opportunities for clinical collaborations in pursuing this end goal.  
Pacemaker technology has rapidly advanced in the last two decades with better rate-
responsive algorithms incorporating timing cycles that can track both the atrial and 
ventricular activity. Various control algorithms have been developed and implemented in 
pacemakers enabling detection of irregular cardiac rhythms and application of rate 
responsive stimulation for modulation of heart rate. To validate effects of feedback 
elimination in-vivo, a contemporary pacemaker can be potentially re-programmed to 
implement the constant DI pacing protocol. Specifically, the pacemaker can be customized 
to detect the RT and TR intervals which correspond to the APD and DI, in real time. After 
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every detected T wave, a time interval equivalent to the predefined constant DI value could 
be activated, at the end of which a pacing stimulus could be applied. 
This is the first attempt at extending the concept of feedback modulation and 
formation of alternans and developing a clinically relevant therapeutic solution for the 
prevention and control of cardiac arrhythmias. This research aimed at developing a 
physiologically relevant and potentially anti-arrhythmic pacing mechanism. It challenged 
the contemporary periodic pacing methodology based on a solid proven mathematical 
foundation and published numerical simulation data. The real-time control algorithm 
developed for the experimental validation of constant DI pacing is a novel implementation 
of closed loop control of isolated whole hearts. It opens the doors for the modulation of 
cardiac electrical activity in real-time during various diseased states and abnormal rhythms. 
Furthermore, it utilizes the spatiotemporally flexible, high resolution technique of optical 
mapping for the assessment of different pacing techniques and their electrophysiological 
effects on whole hearts. Most importantly, the successful adaptation of constant DI pacing 
into a clinically viable device could improve the quality of life of patients suffering from 
abnormal cardiac rhythms. 
7.2 Real-time Closed Loop Optical Mapping 
To eliminate feedback and control the DI on a beat-by-beat basis, we currently 
utilize the electrical signal from real-time ECG data. As described in Chapter 5, we detect 
T-waves on the ECG and control the TR intervals in real-time while optical mapping is 
performed in conjunction to record 2D videos during the experiment. The optical videos 
are then post processed to assess the spatio-temporal efficacy of the pacing technique in 
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suppressing alternans. However, another potentially useful technique for cardiac control 
would be to utilize 2D feedback information based on the optical signal emitted, in order 
to provide the flexibility of targeting specific substrates across the whole heart. Hence, an 
algorithm to detect an action potential in real-time from the fluorescence signal emitted 
during optical mapping, and to enable control over the succeeding DI, could help utilize 
the high resolution features of the optical signal, combined with the spatial flexibility of 
2D imaging. 
There are a number of technical challenges in incorporating closed loop control 
using optical signals. (1) Fluctuations in fluorescence intensity make it difficult to track an 
action potential in real time. The baseline can vary based on experimental conditions and 
needs to be identified in real time during each run. (2) Considering the large size of the 
two-dimensional images, communication between the camera and computer memory can 
act as a bottleneck in high-speed signal acquisition. Most cameras use a frame grabber that 
captures images sequentially and transmits to the host computer. This introduces a latency 
in the signal processing. (3) Operating systems like Microsoft Windows or Linux, are not 
hard real time operating systems and have inherent processing latencies. For successful 
determination of APD and control over DI, the system delay needs to be maintained under 
30ms. (4) Motion artefacts can be present during optical mapping experiments which make 
it essential to have spatial and temporal filtering to extract useful information from the 
feedback signal. Performing spatiotemporal filtering on discrete data samples in real time 
with minimal added latency forms an interesting challenge. Here, as a first step, I 
implemented a control algorithm and validated it using previously acquired optical videos 
  96 
[90]. Two distinct aspects of the algorithm were tested, namely real-time APD capture and 
signal processing for real-time APD detection and DI control.  
Fig.7.1A shows the schematic of the optical mapping setup and the algorithm for 
real-time detection of APD and stimulation. The setup consisted of a fast 14-bit, 80 × 80-
pixel resolution camera (Little Joe, RedShirt Imaging, SciMeasure) connected to a personal 
computer (PC, with windows XP OS, CPU 2.5 GHz, 3GB RAM) using a camera link 
digital camera interface (EDT PCI DV C-Link/SC). The real-time data was processed using 
a LABVIEW based custom written program. To account for experimental noise and motion 
artifacts, spatial filtering was performed. The average optical data from a specified region 
of interest (3x3 matrix of pixels) was processed on a frame by frame basis and the start and 
end of an action potential was detected in real-time. At the end of each detected action 
Figure 7.1. A) Schematic of the optical mapping system for real time APD measurement; 
B) Flowchart summarizing the APD detection algorithm 
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potential, a stimulus was applied using a stimulator (World Precision Instruments, A385, 
Stimulus Isolator).  
The APD detection algorithm (Fig.7.1B) consisted of acquiring the optical images 
in real time from the CCD cameras and performing initial moving average filtering in order 
to remove noise from the raw data. The moving average queued a predefined number of 
input data samples and calculated the average value. With each new data sample, the top 
of the queue was emptied and the average was recalculated based on the updated data 
sequence. The queue length for calculating the moving average could be adjusted based on 
the variable noise artifacts in input data observed under experimental conditions. The 
action potential peaks were then detected from the filtered data.  The repolarization 
threshold was calculated in real-time for each action potential based on the peak amplitude. 
Figure 7.2 Left: An image of the LV surface from the recorded optical mapping movie; 
Right: Action potential traces from a single pixel denoted by *, from the LV of a rabbit 
heart paced at a BCL of 280ms and 180ms 
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APD80 (APD calculated at 80% repolarization) was used to detect the end of each action 
potential, post which a stimulus was applied. 
In order to test the real-time APD detection algorithm, optical movies recorded 
from the LV surface of the rabbit heart at two different BCLs were first analyzed. Fig.7.2 
shows the action potential traces from a single pixel of the rabbit heart for a BCL of 280ms 
and 180ms. The pixel was chosen arbitrarily for validation purposes and showed similar 
results for different locations of the heart. Note that the action potential traces are inverted, 
which is a property of the dye used for recording the voltage activity. The APD80 from the 
single pixel location was calculated, denoted by * in Fig.7.2 for both the BCLs. The APD80 
was 176.213ms and 128.96ms for a BCL of 280ms and 180ms respectively. The modified 
optical mapping setup shown in 
Fig.7.1A was then used to test the 
capture of action potentials in real 
time. Previously recorded optical 
mapping movies of the rabbit 
heart (see Fig.7.2) were replayed 
in real-time and the algorithm to 
capture the action potentials was 
tested. Fig.7.3 shows the action 
potential traces captured using the 
real-time software. 
Figure 7.3 Traces of action potential at BCL 
280ms and 180ms using real-time APD 
detection software 
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As seen from Fig.7.3, the real-time software captured the train of action potentials 
generated at both the BCLs in the paced rabbit heart. There was a close correspondence to 
the optical movies recorded earlier (Fig.7.2). As seen from Figs.7.2 and 7.3, the shape and 
duration of the action potentials recorded was similar and varied in accordance with the 
BCL. Note that the x axis in Fig.7.3 is not time but the frame number. The real time data 
was captured, processed and 
displayed on a frame-by-frame basis. 
Therefore, for a sampling rate of 1 
kHz, we could potentially capture 1 
frame/ms. However, due to the 
inherent system delays introduced by 
the camera frame grabber and the 
signal processing algorithm, the 
actual frame rate was lower than the 
maximum. This was still within the 
rate required to capture the start and 
detect the end of successive action 
potentials as seen from Fig.7.3. The 
real time data (Fig.7.3) however, was 
much noisier than the original data 
(Fig.7.2) since no filtering or other 
processing was performed. The pixel 
A 
B 
C 
D 
Figure 7.4 Real-time detection of action 
potential and application of stimulation 
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location used to detect the action potential could be changed during experiments, thus 
providing the flexibility to get feedback based on different regions of the heart.  
Next, the APD detection and stimulation algorithm (see Fig.7.1B) was tested. 
Fig.7.4 shows the step by step results of the APD detection and stimulation algorithm that 
was tested on a simulated raw data sampled frame-by-frame to emulate the actual 
experimental conditions. The simulated raw data is shown in Fig.4A, which consists of a 
train of action potentials read by the APD detection algorithm as a sequence of data 
samples, similar to the real-time experimental data. Note that the raw data shown in 
Fig.7.4A is similar to the action potential traces captured in real-time (Fig.7.3). Panel B 
shows the application of the moving average filter on the raw data. It calculates the average 
based on a queue of ten data points at each instant. In order to calculate the peak of an 
action potential from the filtered data, the maximum change in voltage or upstroke of action 
potential was detected (panel C). The repolarization threshold was calculated based on the 
detected peak and was used to identify the end of the action potential and thus, to determine 
APD. In panel D, the application of a stimulus at the end of the detected APD is shown. 
Fig.7.4, thus shows that the APD detection algorithm can process instantaneous real-time 
raw data and identify an APD. Although the stimulus here is applied at the end of each 
detected APD, the algorithm can be used to control the DI and apply stimulation after a 
predefined constant DI. These results, thus present a novel real-time APD detection 
technique for the control of cardiac restitution and implementation of the constant DI 
pacing technique.	 
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Alternans has been shown to be a local phenomenon that gradually develops 
spatially across the whole heart. The method described above, provides flexibility in terms 
of the number of action potentials sensed and their locations on the heart for feedback 
control information. This holds a distinct advantage compared to previous methods for the 
control of APD that were based on single electrode sensing and smaller tissue sizes. 
This study was designed as a preliminary step to verify the feasibility of a novel 
optical mapping based real time feedback control system to capture and detect action 
potentials. A qualitative analysis of the proposed algorithm was performed. However, 
further quantitative studies are essential to characterize the efficacy and utility of the 
system. Also, the system used was a soft real time system limited by the inherent latencies 
of the camera frame grabber and Windows XP based PC. Further improvements in the 
performance and speed can be achieved using a hard real time system. 
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